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SUMMARY 
 
Background: The wall of small blood vessels consists mainly of endothelial and smooth 
muscle cells. To enable a uniform response of the vessel to agonists, a coordination and 
synchronization of the response of individual endothelial and smooth muscle cells is considered 
necessary. Such coordination may be achieved by intercellular communication via gap junctions 
(GJs). GJs are the intercellular channels built by transmembranous proteins, called connexins 
(Cxs). There are several Cxs expressed in vascular cells – Cx37, Cx40 Cx43 and Cx45, of which 
Cx37 Cx40 and Cx43 are found in the endothelium.  
Earlier experiments by our group revealed that the calcium permeability of GJs containing 
Cx37, is specifically reduced by the endothelial autacoid, nitric oxide (NO) (Kameritsch et al., 
2005). Especially the exchange of calcium via myoendothelial junctions, where Cx37 is found to 
be preferentially located, may be of importance for the endothelial calcium homeostasis, which is 
essentially involved in endothelial autacoid synthesis and signal transfer (Pogoda, Fuller, Pohl, & 
Kameritsch, 2014). Therefore, this thesis aimed for a better understanding of the molecular basis 
by which NO could affect the calcium permeability of Cx37 containing GJ. 
 
Methods: The studies were performed in cultured HeLa cells. The advantages of using 
HeLa cells are that wild type (wt) HeLa cells do not express Cxs and can be stably transfected to 
express a defined connexin to establish homotypic GJs. Since native Cx37 is hardly detectably by 
classic Western blot techniques due to the lack of appropriate antibodies, HeLa cells were 
transfected with Cx37 to which a green fluorescent protein (GFP) tag was added at the end of the 
C-terminus of the Cx37 protein (Cx37GFP). In addition to the full length Cx37GFP, mutants 
were generated lacking increasing parts of the C-terminus: a mutant which lacks the last 14 
amino acids (aa) of the C-terminus named HeLadel319; a mutant which lacks the last 37 aa of the 
C-terminus named HeLadel296; and a full length mutant in which one single tyrosine (Tyr/ Y) at 
position 332 was exchanged by alanine (A) named HeLaY332A. The cells were characterized 
using immunofluorescence, polymerase chain reaction, Western Blot and mass spectrometry. The 
permeability of gap junctions to calcium was tested after loading the cells with the fluorescent 
calcium indicator (Fura 2-AM). By mechanical stimulation of one single cell with a glass rod, 
local calcium increases were generated and the spread of the calcium change to adjacent cells was 
quantified by determining the number of reacting cells in confluent monolayers. All experiments 
were performed in the presence of suramin to prevent potential paracrine stimulatory effects of 
adenosine triphosphate (ATP) on cytosolic calcium stimulation by mechanically induced ATP 
release via hemichannels formed by connexins. 
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Results: Immunofluorescence imaging using laser scanning confocal microscopy revealed 
that in HeLaCx37GFP cells, the GFP tags and Cx37 had the same subcellular localization. 
Furthermore, Cx37 messenger ribonucleic acid (mRNA) and protein were observed in the 
HeLaCx37GFP cells. Experiments with HeLaCx37GFP cells showed an intact functional 
coupling as assessed by the spreading of calcium increases to 47±5 % of cells per visual field. 
Pre-exposure of the cells to NO S-nitroso-N-acetyl-D,L-penicillamine (SNAP), 20 µM (for 20 
min) reduced the coupling in a dose dependent manner down to 23±3 %. Similar effects were 
observed by exposing the cells to acidosis (pH 6.6 for 15 min) and H2O2 (100 mM for 15 min). 
Inhibition of tyrosine phosphatases by orthovandate (100 µM) abolished the inhibitory effect of 
NO whereas an inhibitor of tyrosine kinases (genistein) exerted similar inhibitory effects as NO 
did. 
Immunofluorescence imaging of the mutant cells HeLadel319 and HeLadel296 revealed 
no quantifiable differences to Cx37GFP full length cells. The mutant cells were channel 
competent as revealed by the spread of calcium increases. There was even a tendency towards 
higher coupling especially in HeLadel319. However, NO treatment had no inhibitory effect 
anymore on cell coupling though low pH and H2O2 still exerted inhibition. In view of the effects 
of tyrosine phosphatase and kinase inhibition described above, we identified a tyrosine in the last 
19 aa of the C-terminus of Cx37 as potential target mediating the NO effects. The full length 
mutant Cx37 Y332A showed indeed no response to NO anymore though subcellular Cx location 
was unaltered and the GJ permeability to calcium was even increased. Again, the inhibitory 
effects of low pH and H2O2 were preserved in this mutant.  
Further attempts to identify the posttranslational modification of Cx37GFP at tyrosine 
332 by mass spectrometry analysis failed. Since, under several cleavage procedures, the last part 
of the C-terminus of Cx37 could not be recovered with sufficient certainty.  
Conclusion: In the present study we showed that Cx37GFP forms functionally intact GJs 
in HeLa cells which allow the same spread of calcium as wt-Cx37 does. The reducing effect of 
NO on the spread of the calcium signal via GJ is specific and requires the presence of the last 19 
aa in the C-terminus of Cx37 as assessed by the mutants Cx37 del296 and del319. The lack of 
NO effects after conservative exchange of tyrosine 332 against alanine suggests that a NO 
mediated modification of this tyrosine forms the molecular basis of the NO mediated inhibition. 
This may be due to a change of tyrosine phosphorylation since the inhibitor of tyrosine 
phosphatases, orthovanadate, abolished the NO effect.  
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ZUSAMMENFASSUNG 
Hintergrund: Die Wand kleiner Blutgefäße besteht hauptsächlich aus Endothelzellen und 
glatten Muskelzellen. Um eine gleichförmige Reaktion des Gefäßes auf Agonisten zu 
ermöglichen, ist eine Koordination und Synchronisation der Antwort diverser endothelialer und 
glatter Muskelzellen nötig. Eine solche Koordinierung kann durch interzelluläre Kommunikation 
über Gap Junctions (GJs) erreicht werden. GJs sind interzelluläre Kanäle welche aus 
Transmembranproteinen – Connexine (Cxs) genannt - bestehen. In vasukulären Zellen werden 
Cx37, Cx40m Cx43 und Cx45 exprimiert, von denen Cx37, Cx40 und Cx43 im Endothel zu 
finden sind. 
Frühere Versuche unserer Gruppe zeigten, dass die Calcium-Permeabilität von Cx37 
enthaltenden GJs spezifisch durch das endotheliale Autakoid Stickstoffmonoxid (NO) reduziert 
wird (Kameritsch et al., 2005). Insbesondere der Austausch von Calcium über myoendotheliale 
Gap Junctions, also Verbindungen zwischen Endothel- und Gefäßmuskelzellen, an denen Cx37 
bevorzugt vorkommt, könnte von Bedeutung für die endotheliale Calciumhomöostase sein. 
Calcium ist ein wichtiges Signalmolekül für die Synthese endothelialer Autakoide (Pogoda, 
Füller, Pohl, & Kameritsch, 2014). Ziel dieser Arbeit war, zu klären, - welche Strukturen von 
Cx37 für diese Wirkung von NO auf von Bedeutung sind.  
Methoden: Die Untersuchungen wurden in kultivierten HeLa-Zellen durchgeführt. Der 
Vorteil bei der Verwendung von HeLa-Zellen ist, dass Wildtyp (wt) HeLa-Zellen keine Cxs 
exprimieren und somit stabil mit definiert mit bestimmten Cxs transfiziert werden können, um 
homotypische GJs zu etablieren. Da natives Cx37 aufgrund mangelnder Qualität käuflich 
erhältlicher Antikörper mittels Western Blot schwer nachweisbar ist, wurden HeLa-Zellen mit 
Cx37 transfiziert, an dessen C-Terminus ein grün fluoreszierendes Protein (GFP) gekoppelt 
wurde (Cx37GFP). Zusätzlich zum Cx37GFP-Wildtyp Konstrukt wurden Mutanten kloniert, 
denen verschiedene Abschnitte des C-Terminus fehlten: eine Mutante, der die letzten 14 
Aminosäuren (aa) des C-Terminus fehlten (HeLadel319); eine Mutante, der die letzten 37 aa des 
C-Terminus fehlten (HeLadel296), sowie eine Mutante, die zwar volle Länge besitzt, aber an 
Position 332 ein Alanin (A) anstatt eines Tyrosins (Tyr/Y) besaß (HeLaY332A). Die Zellen 
wurden mittels Immunfluoreszenz, Polymerasekettenreaktion, Western Blot und 
Massenspektrometrie charakterisiert. Die Permeabilität der Gap Junctions gegenüber Calcium 
wurde durch Beladung der Zellen mit dem fluoreszierenden Calciumindikator (Fura 2-AM) 
getestet. Durch mechanische Stimulation einer einzigen Zelle mit einer kleiner Pipette wurde eine 
lokale Calciumerhöhung erzeugt und die Ausbreitung von Calcium auf benachbarte Zellen wurde 
durch Bestimmung der Anzahl der mit einer Caclium Erhöhung reagierenden Zellen in den Zell-
Monolayern quantifiziert. Alle Experimente wurden in Gegenwart von Suramin durchgeführt, um 
potentielle parakrine stimulatorischen Wirkungen von Adenosintriphosphat (ATP) auf die 
cytosolische Calcium Konzentration durch mechanisch induzierte Freisetzung von ATP über 
Connexin-Hemikanäle zu verhindern. 
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Ergebnisse: Immunfluoreszenz-Bildgebung mittels konfokaler Mikroskopie zeigte, dass 
in HeLaCx37GFP Zellen eine Co-Lokalisation von GFP und Cx37 vorlag. Außerdem wurden 
sowohl Cx37 Boten-Ribonukleinsäure (mRNA) als auch Cx37 Protein in den HeLaCx37GFP 
Zellen beobachtet. Experimente mit HeLaCx37GFP Zellen zeigten eine intakte funktionelle 
Kopplung, die durch einen Calcium-Anstieg in 47 ± 5% der Zellen pro Gesichtsfeld ermittelt 
wurde. Eine Inkubation der Zellen mit NO (S-Nitroso-N-Acetyl-D, L-Penicillamin (SNAP), 20 
µM für 20 min) reduzierte die Kopplung in einer dosisabhängigen Weise auf 23 ± 3% der Zellen 
pro Gesichtsfeld. Ähnliche Effekte wurden durch Behandlung der Zellen mit Azidose (pH 6,6 für 
15 min) und H2O2 (100 mM für 15 min) beobachtet. Eine Hemmung der Tyrosinphosphatasen 
durch Orthovandat (100 µM) hob die hemmende Wirkung von NO auf, wohingegen ein Tyrosin-
Kinase-Inhibitor (Genistein) eine ähnlich hemmende Wirkung wie NO hatte. 
Immunfluoreszenz-Analysen der mutierten Zellen HeLadel319 und HeLadel296 ergab 
keine messbaren Unterschiede verglichen mit dem „Volle-Länge-Konstrukt“ Cxγ7GFP. Es gab 
sogar eine Tendenz hin zu höherer Kopplung vor allem in HeLadel319-Zellen. Eine Behandlung 
mit NO hatte in diesen Zellen aber keinen hemmenden Effekt mehr auf die Zellkopplung obwohl 
andere Gap Junction Blocker wie ein niedriger pH-Wert oder H2O2 noch immer eine Hemmung 
bewirken konnten. Im Hinblick auf die bobachteten Effekte von Tyrosin-Phosphatase- bzw. 
Tyrosin- Kinase-Hemmung identifizierten wir ein Tyrosin in den letzten 19 Aminosäuren des C-
Terminus von Cx37 als potentielles Ziel für die NO-Effekte. Die Mutante Y332A Cx37 zeigte in 
der Tat keine Reaktion mehr auf NO. Die subzelluläre Cx-Lokalisation der Y332A Cx37 Zellen 
blieb unverändert und die Durchlässigkeit der GJ für Calcium war sogar erhöht. Die hemmenden 
Wirkungen von niedrigem pH-Wert und H2O2 blieben auch bei dieser Mutante erhalten. 
Weitere Versuche, die posttranslationale Modifikation von Cx37GFP an Tyrosin 332 
durch Massenspektrometrie zu ermitteln, schlugen fehl, da nach mehreren Spaltungsverfahren der 
letzte Teil des C-Terminus von Cx37 nicht mit hinreichender Sicherheit dargestellt werden 
konnte. 
Fazit: In der vorliegenden Studie haben wir gezeigt, dass Cx37GFP funktionell intakte 
GJs in HeLa-Zellen ausbildet, die die gleiche Ausbreitung von Calcium-Signalen wie in Zellen 
mit Wildtyp-Cx37 (wt-Cx37) ermöglichen. Die hemmende Wirkung von NO auf die Ausbreitung 
des Calciumsignals über GJ ist spezifisch und erfordert das Vorhandensein der letzten 19 
Aminosäuren des C-Terminus von Cx37, was durch die Mutanten Cx37 del296 und del319 
gezeigt werden konnte. Da NO keinen hemmenden Effekt mehr auf Mutanten hatte, die anstatt 
Tyrosin ein Alanin an Position 332 hatten, liegt der Schluss nahe, dass eine NO-vermittelte 
Modifikation dieses Tyrosins die molekulare Basis der NO-vermittelten Hemmung bildet. Die 
Ursache hierfür könnte eine Veränderung der Tyrosinphosphorylierung sein, da der Tyrosin-
Phosphatase-Inhibitor Orthovanadat den Effekt von NO aufheben konnte.  
 
INTRODUCTION 
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I. INTRODUCTION 
 
I.1 Structure and function of blood vessels 
Blood vessels have a variety of functions: transport of the blood from and to the heart, 
transport of oxygen from the lung to peripheral organs, and they allow for the exchange of 
oxygen, carbon dioxide, water and small molecules between the blood and surrounding tissues in 
the capillary regions of the circulatory system. 
The vascular functions are necessary for individual cells in their synchronized actions. 
Modifications in the diameter of the vessels and also their blood flow can only be achieved with 
coordinated diameter change along the vascular bed (A. Harris, 2009). All blood vessels except 
the capillaries have in principle a 3 layered structure of the vascular wall comprising of an intima, 
formed by endothelial cells (EC) and their basal lamina. The second layer, the media, is built 
mainly by smooth muscle cells (VSM). The outermost layer, the adventitia, contains mainly 
fibroblasts, pericytes and other non-muscle cell types (Majesky, Dong, Hoglund, Mahoney, & 
Daum, 2011) (Figure I-1). The main vascular cells, the EC as well as the VSM, can communicate 
with each other since they are coupled by intercellular connections, called gap junctions, GJs (A. 
Harris, 2009). Previous studies have shown (Kurjiaka & Segal, 1995; de Wit et al., 2000) that EC 
can communicate via gap junctions over a relatively long-distance, thereby contributing to the 
coordination of vessel diameter changes. A study of Kameritsch et al. demonstrates that calcium 
can be transferred via gap junctions to adjacent endothelial cells thereby regulating the 
endothelial response to vasoactive agonists (Kameritsch, Pogoda, Ritter, Munzing, & Pohl, 
2012). 
 
Figure I-1 Vascular wall structure. The vascular wall has several layers: intima, media and adventitia. Intima contains the 
endothelial cells and internal elastic lamina; media has smooth muscle cells and adventitia contains fibroblasts 
(http://pixgood.com/artery-wall-anatomy.html). 
INTRODUCTION 
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Regulation of blood flow in arteries comprises several pathways. Vasomotor stimuli can 
affect the VSM directly, thereby inducing vasoconstriction or – relaxation, or they act indirectly 
on EC eliciting the release of endothelial autacoids. Direct effects are, for example, a relaxation 
of VSM due to changed partial pressures of carbon dioxide (pCO2) or pressure of oxygen (pO2) 
induced by metabolic activity of the cells. The sympathetic neurotransmitter, norepinephrine can 
also produce vasoconstriction when binding to VSM alpha receptors. Especially in skeletal 
muscle vessels, epinephrine and norepinephrine can also induce vasodilatation by stimulating 
beta adrenergic receptors under special conditions. Other important hormones regulating the tone 
of VSM are e.g. natriuretic peptides or angiotensin II, respectively. 
EC-dependent vasomotor responses (predominantly vasodilation) are elicited by 
mechanical (shear stress) or local humoral stimuli such as histamine, bradykinin, or ATP. 
Endothelium dependent dilatation is mediated by factors like nitric oxide (NO) or the 
endothelium derived hyperpolarizing factor (EDHF) finally inducing a relaxation in the smooth 
muscle cells (SMC). Of note, at least in small arterioles which are most important for the control 
of tissue blood flow, underlying VSM can also be influenced via myoendothelial gap junction 
communication (Widmaier E. P., 2008; de Wit & Griffith, 2010; Korthuis, 2011; Straub, Zeigler, 
& Isakson, 2014; Sandow, Senadheera, Bertrand, Murphy, & Tare, 2012). 
I.2 Gap Junctions 
As pointed out above, the vascular GJs have been implicated in control of vascular tone and 
blood pressure. These include mainly endothelium-derived hyperpolarization of the underlying 
smooth muscle (usually termed as EDHF responses) and the conducted vasodilation and 
constriction in the microcirculatory network (Pogoda et al., 2014; Rummery & Hill, 2004).  
Figure I-2 depicts schematically the location of GJs in the blood vessels. They are 
expressed between cells in the smooth muscle or endothelial layer, but, at least in small arterioles, 
between SMC and EC (myoendothelial gap junctions MEGJ). The occurrence of MEGJ is 
inversely correlated with arterial diameter, suggesting that MEGJ play an important role in 
smaller resistance vessels (Hill, Rummery, Hickey, & Sandow, 2002). 
INTRODUCTION 
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Figure I-2 Localization of cell junctions in vascular wall. Longitudinally orientated endothelial cells are well coupled by large 
cell junctions, whereas smaller cell junctions are more heterogeneously located among the SMC. In some arteries, the SMC may 
be coupled to the endothelial cells by small MEGJs that traverse the internal elastic lamina. Original picture taken from 
(Rummery & Hill, 2004).  
 
Figure I-3 shows a thin section of two adjacent cultured fibroblasts. Their cells membranes 
contain clusters of small intercellular channels. The right part of the picture depicts a freeze 
fracture image also showing the cluster which consists of GJs (Alberts, 2002; Goodenough & 
Gilula, 1974), the GJs allow the transfer of molecules from one cell to the other. 
 
Figure I-3 Gap junctions in fibroblasts (A) depicts a thin-section and (B) a freeze-fracture electronmicrograph where the cluster 
of homogeneous intramembrane particles are gap junctions. Each intramembrane particle corresponds to a connexon. Original 
picture taken from (Alberts, 2002). 
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Gap Junctions are principally formed by a family of transmembrane proteins, the 
connexins. Connexins are members of a family with 20 proteins in mice and 21 proteins in 
humans, named after the molecular mass of their complementary deoxyribonucleic acid (cDNA). 
According to their structure they can also be assigned to an α-group (Cx37, Cx40, Cx43, see 
Table I-1),  group and  group (Cx45) (Kumar & Gilula, 1996; Sohl & Willecke, 2003; 
Johnstone, Isakson, & Locke, 2009). Protein sequence identity mouse versus human is 91% for 
Cx37, 85 % for Cx40, 98 % for Cx43, 98 % for Cx45 (Sohl & Willecke, 2004).  
 
Table I-1 The connexin family. The Cx gene names have been adopted from those suggested by Sohl and Willecke and using the 
phylogenetic tree from Cruciani and Mikalsen. Original table taken from (A. Harris, 2009). 
Figure I-4 shows that 6 Cxs (A) form a connexon (B) which are also called a hemichannel. 
Two connexons located in adjacent cells may couple, thereby forming an intercellular channel 
which allows passage of small molecules and ions to adjacent cells (C) (Dbouk, Mroue, El-
Sabban, & Talhouk, 2009; Goodenough & Paul, 2009). Each GJ has a lumen of about 20 
Angstrom (Å) (Berg, 2013). 
 
Figure I-4 Schematic representation of gap junctions. GJs are formed from 2 hemichannels (connexons) which may have the 
same or different composition of Cxs. Connexons have in composition six different or identical Cxs. Picture modified from 
(Alberts, 2002). 
 
I.2.1 Connexin structure 
One Cx has four transmembrane domains (m1, m2, m3, m4), thereby forming two 
extracellular loops (el1, el2) between m1–m2 and m3-m4. One short cytoplasmic loop (cl) is 
located between m2-m3. The amino-terminus (NH2, N-terminus) and carboxyl terminus (COOH, 
C-terminus) are located intracellularly (Figure I-5). Most of the protein sequence is highly 
conserved for all types of Cxs. In contrast, the cytoplasmic loop (cl) and especially the C-
terminus differ significantly and are responsible for the different functional properties of channels 
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formed by different Cxs (Morel, Burnier, & Kwak, 2009). The C-terminus acts as a regulatory 
domain in this context and being a substrate for specific kinases as well as other protein partners 
(Thomas et al., 2002; Duffy, Delmar, & Spray, 2002; Giepmans, 2004). The regulation of Cx in 
GJs is specific and this is the reason why Cxs function cannot be replaced by other Cxs (Figueroa 
& Duling, 2009; Figueroa, Isakson, & Duling, 2004; Haefliger et al., 2006). 
 
Figure I-5 Connexin structure. Membrane topology of connexins. Diagram of a Cx depicting its orientation according to the 
plasma membrane (m1 to m4) with the amino-terminal and carboxyl-terminal domain (NH2 and COOH) located on the 
cytoplasmic side of the membrane. The protein contains two extracellular loops (el1 and el2) and a cytoplasmic loop (cl). 
Original picture taken from (Wagner, 2008). 
 
The vascular Cxs (Cx37, Cx40, Cx43 and Cx45) are not expressed uniformly (Berg, 
2013). In EC Cx37, Cx40, and Cx43 are found, whereas in SMC Cx43 and Cx45 are mainly 
expressed (A. Harris, 2009; Rummery & Hill, 2004) but the relative expression differs with 
regard to vessel type and region (Sandow et al., 2003). In most studies Cx37 and 40 was found in 
EC only – which agrees with our group findings in the mouse - but Cx37 was also described in 
VSM, so the vessel`s type might be important (Schmidt, Wolfle, Boettcher, & de Wit, 2008). 
However; in some vascular regions, expression of Cx37 has also been described in the media 
(Sandow et al., 2003). The Cx composition of GJs depends on vascular layer and species (Looft-
Wilson, Payne, & Segal, 2004; Sandow et al., 2003). At MEGJ, some groups found only Cx37, 
Cx40, and Cx43 (Haddock et al., 2006; Isakson, Best, & Duling, 2008; Sandow, Neylon, Chen, & 
Garland, 2006). Therefore each Cxs could play a specific function within the vascular tree and be 
differently regulated (Schmidt et al., 2008). Simon et al. found that Cx37 is present at the border 
of EC but not at VSM (Simon & McWhorter, 2003). Isakson et al. located also Cx37 in EC and 
even more, observed that at the contact point between EC with vascular smooth muscle cells 
(VSMC) the Cx37 was absent (Isakson & Duling, 2005). 
In small resistance arteries, Pogoda et al. demonstrated that within the internal elastic 
lamina two Cxs endothelial Cx37 and Cx43 are closely located to each other in the whole regions 
of the internal elastic lamina, where MEGJ can occur. In co-cultured EC and SMC bidirectional 
INTRODUCTION 
10 
 
vascular calcium signal propagation at MEGJ is controlled by NO. The inhibition of GJ 
communication by NO traps the cytosolic calcium within the endothelial cells leading to an 
intensified endothelial response (Pogoda et al., β014). 
 
I.3 Connexin 37 / GJA 4 
The structure of Cx37 is similar to that of other Cxs, as described above. In brief: 4 
transmembrane domains (yellow Figure I-6), 2 extracellular loops (blue), a cytoplasmic loop (cl) 
with 20 amino acids (aa purple) and cytosolic located N- (black) and C-terminus (red). The C-
terminus differs from other Cx (Johnstone et al., 2009). Cx37 has the smallest pore in spite of 
having the largest unitary conductance > 300 picosiemens (pS) compared to other Cxs 
(McKinnon et al., 2009; Veenstra, Wang, Beyer, Ramanan, & Brink, 1994; Looft-Wilson et al., 
2004). 
 
Figure I-6 Schematic representation of Cx37 structure. Cx37 have NH2 in black, transmembrane domains (m1-4) in yellow, 
extracellular loops (el1-2) in blue, cytoplasmic loop (cl) in purple and C-terminus (COOH) in red.  
 
As mentioned before, Cx37 is highly expressed in the vasculature and seems to be 
important for the gap junctional communication of endothelial cells with smooth muscle cells via 
myoendothelial gap junctions (Pogoda et al., 2014). A decrease of endothelial Cx37, which was 
found in arteries where endothelial cells overlap atherosclerotic plaques, could therefore be 
associated with the functional loss of these vessels (Kwak, Mulhaupt, Veillard, Gros, & Mach, 
2002; Pfenniger, Chanson, & Kwak, 2013). However, a global knockout (KO) of Cx37 does not 
lead to any obvious vascular phenotype. 
I.3.1 Connexin modifications 
Cxs may undergo various posttranslational modifications (PTM) like (de-) phosphorylation, 
hydroxylation, palmitoylation, nitrosylation, nitration and acetylation (Dbouk et al., 2009). The 
most studied modifications are phosphorylations of tyrosine (Tyr), threonine (Thr) and serine 
(Ser). It can be observed in all Cxs being expressed in the vasculature and additionally in Cx31, 
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Cx32, Cx46, Cx50 and Cx56, while no modification by phosphorylation is known for Cx26 
(Dbouk et al., 2009). The C-terminus is the primary target for phosphorylation. Moreover some 
Cxs are phosphorylated at the cytoplasmic loop (Lampe & Lau, 2004) (Solan & Lampe, 2009a). 
The majority of phosphorylation occurs at the serine residues but also tyrosine phosphorylation 
can be observed. A plethora of kinases have been shown to be involved into Cx phosphorylation 
such as cyclic adenosinmonophosphate (cAMP)-dependent protein kinase (PKA), cyclic 
guanosine monophosphate (cGMP)-dependent kinase (PKG), protein kinase C (PKC), Ca2+/CaM-
dependent kinase II (CaMKII), the Rous sarcoma virus v-Src, cellular proto-oncogene tyrosine-
protein kinase Src (c-Src), casein kinases and mitogen-activated protein kinase (MAPK) (Kwak 
et al., 1995; Lampe & Lau, 2004). Experiments by our group revealed that NO can also affect the 
permeability of homo- and heterotypic GJs containing Cx37 but the specific mode of the 
modification is still not known. However it has been shown that it is not cGMP dependent, since 
the soluble guanylyl cyclase inhibitor - oxadiazole-[4,3-a]-quinoxalin-1-one (ODQ 10 mM, 20 
min) had no effect (Kameritsch et al., 2005). 
 
I.4 Nitric oxide  
In endothelial cells, NO is produced by the NO synthase (NOS) using L-arginine as a 
substrate. NO is constitutively produced, but its synthesis is increased when EC are stimulated by 
shear stress or vasomotor agonists such as histamine, bradykinin or Substance P (see Figure I-7). 
NO can diffuse to the VSM (Tousoulis, Kampoli, Tentolouris, Papageorgiou, & Stefanadis, 
2012), eliciting vasodilation due to an increase of 3`-5`cyclic guanosine monophosphate (cGMP) 
or activation of potassium channels (Francis, Busch, Corbin, & Sibley, 2010). cGMP activates 
the protein kinase G (PKG) pathway. The latter involves activation of the myosin light chain 
phosphatase, activation of calcium-ATPases (and therefore reduction of cytosolic Ca2+) and an 
inhibition of phospholipase C (PLC)-dependent activation in VSM (Murthy, 2006). 
 
Figure I-7 Synthesis of NO in Endothelial cells. Several agonists (acetylcholine, histamine, thrombin, serotonin) and vasoactive 
substances (bradykinin) bind to their receptors (R/B2) leading to a calcium increase. The high calcium concentration activates the 
endothelial NOS (eNOS) which deaminates L-arginine to L-citruline and NO. Original picture taken from (Tousoulis et al., 2012). 
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NO cannot only be formed in endothelial but also in other cells (e.g. VSM), mainly under 
inflammatory conditions (Cannon, 1998). It can also be generated pharmacologically by so called 
NO-donors (Yamamoto & Bing, 2000). They have, independently of the endothelium, the ability 
to release NO (in vitro and in vivo). They are categorized in different chemical classes (organic 
nitrates, S-nitrosothiols, sydonimines, sodium nitropusside / SNP and NONOates) (Megson & 
Webb, 2002). S-nitroso-N-acetylpenicillamine (SNAP), which was used in our study, belongs to 
the S-nitrosothiols class (Miller & Megson, 2007; Yamamoto & Bing, 2000). 
Previous studies of our laboratory showed that NO donors (SNAP and SNP) are able to 
reduce communication via Cx37 containing gap junctions: NO specifically reduced cGMP-
independently of the intercellular communication in the presence of Cx37, which was 
demonstrated for intercellular dye spreading (Kameritsch, Hoffmann, & Pohl, 2003). In a recent 
study, Pogoda et al. demonstrated in small resistance arteries that endothelial Cx37 and Cx43 
(probably from SMC layer) are located close to each other within the internal elastic lamina and 
NO controls bidirectional vascular calcium signal propagation at MEGJ in co-cultured EC and 
SMC (Pogoda et al., 2014). Whilst these previous studies excluded that the NO effects were 
mediated via cGMP and hence via cGMP-dependent kinase (PKG) dependent phosphorylation at 
one of the putative PKG phosphorylation sites, (Kameritsch et al., 2005) it remains still elusive 
how NO is exerting its inhibitory effect on Cx37 containing GJ permeability.  
Morel et al. showed two phosphorylation sites at S319 and P319 Cx37 (Morel et al., 
2010). Burt et al. suggested equivalent binding sites for Cx37: (compared with Cx43) Ser 275 
(for MAPK) and Ser 282 (for PKC) (Burt, Nelson, Simon, & Fang, 2008). 
 
I.5 Hypothesis and aims of the study 
We hypothesized that NO may exert its effect by direct or indirect modification of one of 
the many regulatory sites of the C-terminus of the Cx37. To verify or reject our hypothesis, we 
therefore aimed to: 
1) develop a HeLa cell model expressing GFP tagged Cx37 and to compare its functional 
properties and subcellular connexin location with the established model of HeLa cells 
expressing wt Cx37. 
 
2) study the effect of NO on the gap junction dependent transfer of calcium (or a calcium 
releasing molecule) to adjacent cells and compare it with the gap junction permeability in 
cells expressing wt-Cx37. 
 
3) identify potential site(s) of NO dependent modulation by studying Cx37 mutants with a 
deletion of terminal amino acid sequences (Cx37 del 296 and Cx37 del 319) . 
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4) study the effects of NO of a mutant in which the potential NO target tyrosine is replaced by 
alanine. 
 
5) identify if possible, the mode of modification by NO of its identified target by mass 
spectrometry. 
We therefore studied the effect of NO on several Cx37 mutants with modified lengths of the 
C-terminus. These studies were performed in HeLa cells rather than vascular cells, since HeLa 
cells do not express connexins in their wild type state, so that Cx37 could be expressed in a 
controlled manner, in contrast to vascular cells which always express several connexins. We 
focused our studies of GJ function and permeability on the calcium changes in adjacent cells after 
mechanical stimulation of a single HeLa cell, which induces GJ transfer of calcium or calcium 
releasing molecules such as inositol 1,4,5-triphosphate (IP3) via GJs as previously shown by our 
group (Kameritsch et al., 2012). Since our previous studies also revealed that the commercially 
available Cx37 antibodies had low quality, we decided to perform all studies in cells in which 
Cx37 was tagged with GFP. 
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II. MATERIALS and METHODS 
II.1 Materials 
II.1.1 Cell lines  
Immortal cervix carcinoma cells (HeLa) were used in this work. The cells were a kind gift from 
Dr. Klaus Willecke (University of Bonn, Germany). HeLa cells, were stably transfected with full 
length Cx37 or different mutants of Cx37 proteins, all tagged with GFP (Kristin Pogoda). 
II.1.2 Plasmides 
 
II.1.3 Antibodies  
 
 
 
Cell line Transfected plasmid 
HeLa Cx37  pBEHpac18mCx37 
HeLa Cx37GFP pcDNA4mCx37VLosGFP 
HeLa Cx37GFP del319 pcDNA4mCx37 del319GFP 
HeLa Cx37GFP del296 pcDNA4mCx37 del296GFP 
HeLa Cx37GFP Y332A pcDNA4mCx37VLosGFP Y332A 
Name Isotype Dilution Molecular 
weight 
kDa 
Application Company 
Primary antibodies 
Cx37  Rabbit anti Cx37  
(C-term) 
1:1000 
 5 % milk powder 
37 WB, IHC Invitrogen 
GFP  Rabbit polyclonal IgG 1:1000  
5 % milk powder 
28 WB, IHC  Abcam 
GAPDH  Mouse monoclonal IgG1 1:5000  
5 % milk powder 
36 WB Chemicon 
Secondary Antibody 
Mouse Goat anti-mouse IgG, 
HRP conjugate 
1:5000 in 5 % 
milk powder 
 WB Calbiochem 
Rabbit Goat anti-rabbit IgG, 
HRP conjugate 
1:5000 in 5 % 
milk powder 
 WB Calbiochem 
Rabbit Alexa Fluor 546 Goat anti 
rabbit IgG  
1:200 in 0.2 % 
BSA in PBS+ 
 IHC Invitrogen 
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II.1.4 Primers 
II.1.5 Media and additives 
 
II.1.6 Solutions and buffers  
 
 
Primer  Sequence  Tm 
o
C Fragment length 
basepairs (bp) 
Company 
For_1Cx37 
Rev_1Cx37 
CCATCTCCCACATCCGATAC 
CCTCCAGCACACTCTTACAC 
59,4 
59,4 
288 Eurofins MWG 
GmbH 
gfp-for 
gfp-rev 
ATGGCTAGTTCCGGAGGT 
ACCGTACAGCTCGTCCAT 
55,97 
55,97 
741 Eurofins MWG 
GmbH 
For_1Cx37 
gfp-rev 
CCATCTCCCACATCCGATAC 
ACCGTACAGCTCGTCCAT 
59,4 
55,97 
1580 Eurofins MWG 
GmbH 
Media  Contains 
Freezing medium  10 % DMSO in FCS  
HeLa Puromycin medium 10 % NCBS, 100 U/ml penicillin, 100 ug/ml streptomycin, 1 ug/ml 
puromycin in DMEM 
HeLa wt medium 10 % NCBS, 100 U/ml penicillin, 100 ug/ml streptomycin in DMEM 
HeLa Zeocin medium 10 % NCBS, 100 U/ml penicillin, 100 ug/ml streptomycin, β00 μg/ml 
Zeocin, in DMEM 
Solution  Contains 
4xLaemmli buffer 250 mM Tris-pH 6.8, 8 % SDS, 40 % Glycin, 0.02 % Bromophenol blue, 
400 mM -Mercaptoethanol 
Commasie staining 
solution 
0.7 mM Coomassie brilliant blue, 10 % acetic acid, 25 % 2-Propanol 
Electrophoresis buffer 124 mM Tris, 960 mM Glycin, 0,5 % SDS 
Fura2-AM 4 µmol/L in PBS+  
Hepes 144 mM NaCl, 3 mM KCl, 1.2 mM NaH2PO4, 3.3 mM CaCl2, 3.2 mM 
MgCl, 11 mM C6H12O6, 10 mM Hepes, pH 7.4 
Hepes++ 30 µM L-NA and 200U/ml SOD in Hepes 
PBS- 138 mM NaCl, 6 mM Na2HPO4, 1 mM KH2PO4, Aqua ad iniectabilia 
PBS+ 136 mM NaCl, 5 mM KCl, 0.58 mM MgSO4, 0.88 mM CaCl2•βH20, 0.84 
mM Na2HPO4•βH20, 0.44 mM KH2PO4, 5.5 mM C6H12O6•H2O, 3.5 mM 
NaHC03, Aqua ad iniectabilia 1000 ml 
RIPA buffer 10 mM Tris/Cl pH 7.5, 150 mM NaCl, 0.1 % SDS, 1 % TX, 1 % 
Deoxycholate, 5 mM EDTA 
TBS-Tween 50 mM Tris, 150 mM NaCl, 0,1 % Tween 20 
Transfer buffer 39 mM Glycin, 48 mM Tris, 0.037 % SDS, 10 % methanol 
Trypsin/EDTA 0,25 % Trypsin, 1 mM EDTA-Na4 in HBSS w/o: Ca, Mg. Phenolrot 
TBE buffer  89 mM Tris HCl, 89 mM Boric acid, 2,5 mM EDTA, Aqua ad 
iniectabilia 1000 ml, pH 8.5 
Freezing medium  FCS, 10 % DMSO 
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II.2 Reagents  
Reagent  Company  
2-Propanol  Merck KGaA 
Acetic acid 100 %  AppliChem GmbH  
Acetone Carl Roth GmbH & Co. KG, Heidelberg, Germany 
Agarose  AppliChem GmbH  
Antibiotic antimycotic solution  
(Amphotericin B, Penicillin, Streptomycin)  
Sigma-Aldrich Chemie GmbH  
Apyrase Sigma-Aldrich GmbH 
Aqua ad iniectabilia  Apotheke Innenstadt, University-Clinic of Munich 
Bovine serum albumin  Sigma-Aldrich GmbH 
Bromophenol blue  Sigma-Aldrich GmbH  
Collagen G Biochrom AG  
Coomassie brilliant blue R-250  Sigma-Aldrich GmbH 
Dimethyl sulfoxide  AppliChem GmbH  
Disodium ethylenediaminetetraacetic acid  AppliChem GmbH  
Disodium hydrogen phosphate dihydrate  AppliChem GmbH  
DNA marker (1kb gene)  Thermoscientific  
Dulbecco’s Modified Eagle Medium  Gibco Invitrogen  
Ethanol  Merck KGaA  
Ethidium bromide  Sigma Aldrich GmbH 
Fetal calf serum Biochrom 
Formaldehyde 37 %  AppliChem GmbH  
Fura 2 AM Calbiochem 
Gel Red Biotium  
Glycerol  AppliChem GmbH  
Glycine  AppliChem GmbH  
Hank’s balanced salt solution  Apotheke Innenstadt, University-Clinic of Munich  
Hepes Apotheke Innenstadt, University-Clinic of Munich 
Hydrochloric acid  Merck KGaA  
Lipofectamine 2000 reagent Invitrogen 
N-nitro-L-arginine Sigma Aldrich GmbH 
Magnesium chloride  Fluka Chemie AG  
Methanol  AppliChem GmbH  
New born calf serum  NBCS, Biochrom 
Nonfat dried milk powder  AppliChem GmbH  
PageRulerTM Prestained Protein Ladder Fermentas 
PBS- and PBS+ Apotheke Innenstadt, University-Clinic of Munich 
Phenol/Chlororform/Isoamyl alcohol Carl Roth GmbH & Co. KG 
Phenylmethylsulfonyl fluoride  Sigma Aldrich Chemie GmbH  
Pluronic Sigma-Aldrich Chemie GmbH 
Potassium dihydrogene orthophosphate  Merck KGaA  
Protein kinase inhibitor Sigma Aldrich GmbH 
Restore western blot stripping buffer Thermoscientific 
S-nitroso-N-acetyl-D,L- penicillamine Biotrend 
Superoxide dismutase Sigma Aldrich GmbH 
Sodium chloride  AppliChem GmbH  
Sodium dodecylsulfate  AppliChem GmbH  
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II.2.1 Kits 
 
Name  Company 
GFP-Trap A nanobeads  ChromoTek 
mRNA extraction  Qiagen 
S-nitrosylation  Cayman Biochem 
RT-PCR Titan one tube Roche 
Chemiluminescence Detection Kit for 
Horseradish Peroxidase 
AppliChem GmbH 
II.2.2 Technical equipment  
Name  Company 
Air flow bench  LaminAir HB 2448, Heraeus Instruments 
Camera  Imago, Till photonics, Germany 
Cell counter  Coulter AcT 8 (Beckman Coulter)  
Confocal laser scanning microscope  Leica TCS SP5 (Leica Microsystems)  
Cooling centrifuge for falcon tubes  Megafuge 1.0R (Heraeus Instruments)  
Cooling centrifuge for microcentrifuge tubes  Biofuge Primo R (Heraeus Instruments)  
Electrophoresis chamber  Peqlab Biotechnologie GmbH 
Fluorescence microscope  Axiovert 200M (Carl Zeiss)  
Axiophot (Carl Zeiss) equipped with a AxioCam 
MRm (Carl Zeiss)  
Gel Doc 1000 station Bio-Rad 
Humidified incubator  Sanyo CO2 Incubator Model MCO-17AI, Sanyo 
Electric Co. Ltd 
Imaging system for western blot analysis 
(CCD camera)  
Digital CCD Camera (ORCA-ER)  
(Hamamatsu Photonics)  
Inverted microscope Axiovert, Zeiss, Germany 
Light microscope  Fluovert FU, Leitz 
Micromanipulator  Eppendorf 5171 
Monochromator-Polychrom IV  TILL Photonics 
Sodium orthovanadate  Alexis Corporation  
Superfect Transfection reagent  Qiagen 
Tetramethylethylenediamine  AppliChem GmbH  
Tris  AppliChem GmbH  
Triton X-100  AppliChem GmbH  
Trypsin-EDTA solution  Sigma-Aldrich Chemie GmbH , PAN Biotech GmbH 
Tween 20  AppliChem GmbH  
Zeocin  Invitrogen β00 μg/ml 
-Mercaptoethanol  AppliChem GmbH  
Orthovanadate 
Suramin 
Genistein 
Sigma Aldrich Chemie GmbH 
Sigma Aldrich Chemie GmbH 
Sigma Aldrich Chemie GmbH 
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pH measurement  PHM 82 Standard pH Meter  
(Radiometer Copenhagen)  
Power Pack P25 Biometra 
Power supply Phero-Stab 0310 Biotec-Fischer 
Spectrophotometer  Eppendorf  
Table centrifuge for microcentrifuge tubes  EBA 12 (Hettich Zentrifugen)  
Thermoblock Eppendorf 
Thermocycler for PCR  Mastercycler ep gradient S (Eppendorf AG)  
Universal puller  Zeitz Instrumente, Augsburg, Germany 
II.2.3 Tools 
Name Company  
Glass coverslips 13mm diameter Helmut Saur 
Cell culture dishes 24 well plates and 10 cm 
dish 
BD Biosciences (BD Falcon)  
Cryovials  Biozym Scientific GmbH  
Polyacrylamide gels 10 % Precise Tris-
Glycine Gels 
Thermo scientific 
Glass pipette GB100F-10 0,58x1.00x100mm Science products GmbH 
Nitrocellulose Blotting Membrane Peqlab Biotechnologie GmbH 
Gel Blotting Papier  Schleicher & Schuell BioScience GmbH 
QIAshredder columns  Qiagen  
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II.3 Methods 
 
II.3.1  Cell culture techniques 
 
II.3.1.1 Cell culture and passaging 
HeLa cells were cultivated in a humidified incubator at 37oC and 5 % CO2. Instruments 
(glass coverslips and tweezers) were autoclaved before use. All procedures were performed in a 
laminar air flow hood. A light microscope was used to monitor cell growing. 
HeLa wt cells were seeded in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10 % new born calf serum (NCBS) and antibiotics (100 U/ml penicillin and 
100 μg/ml streptomycin, HeLa wt medium). HeLa Cx37 medium additionally contained 
puromycin (1 μg/ml). HeLa Cxγ7GFP cells and all mutants were cultivated in HeLa wt medium 
supplemented with Zeocin (200 μg/ml). Cells were passaged after reaching confluence and 
cultivated in different cell culture dishes (60 mm, 100 mm and 24 well plates). To detach cells 
from the bottom of the culture dish, cells were washed with PBS+ and then incubated in a 
solution containing 0.5 % trypsin and 0.2 % EDTA. After 5 minutes the detached cells were 
suspended in the appropriate cell culture medium. The cell suspension was transferred to new cell 
culture dishes and diluted to the desired concentration with fresh cell culture medium. 
II.3.1.2 Transfection of HeLa wild type cells  
HeLa cells were stably transfected with full length Cx37 or different mutants of Cx37 
proteins, all tagged with GFP (Table II.1.2) (Elfgang et al., 1995). 
 
 
 
 
 
 
 
 
Figure II-1 Map of plasmid pcDNA4 used in transfection. Picture modified from (J. V. Behrens, 2011) 
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Cells were either transiently or stably transfected. After transient transfections of the cells, 
deoxyribonucleic acid (DNA) was not integrated into the eukaryotic genome of cell and was lost 
during mitosis. During stable transfection plasmid DNA was integrated in the cell genome and 
was transmitted to the descendants. To select the stable transfected cells, the DNA plasmid 
contained a gene which conferred them antibiotic resistance (Figure II-1). 
The transfection was performed using Lipofectamine 2000 reagent. HeLa wt cells were 
seeded in 6 well or 24 well plates in medium without antibiotics at the appropriate density as to 
reach a 90-95 % confluence the next day. The transfection was done according to the kit protocol. 
In short:  
1. DNA was diluted in the appropriate amount of medium without serum.  
2. Lipofectamine 2000 transfection reagent was diluted in the appropriate amount of Opti-MEM 
Reduced Serum Medium and incubated for 5 minutes at room temperature (RT).  
3. After incubation time, the diluted DNA and Lipofectamine were combined, mixed gently and 
incubated for 20 minutes at room temperature.  
4. The complexes were added to each well containing cells and medium. Cells were cultivated at 
37oC in a 5 % CO2 incubator for 6h. After 6h, medium was changed with wt type medium and 
cells were grown up for 18-48h.  
In the final stage, the medium was removed and selection medium containing Zeocin was 
added. After this, the cells were used for Western Blot, RT-PCR, and calcium measurements. 
 
HeLa wt cells were transfected with differently modified mouse Cx37 encoding DNA fragments 
(Figure II-2): 
1. HeLa Cx37GFP express Cx37 fused to GFP (Kristin Pogoda). 
2. HeLadel319 express GFP-tagged Cx37 which lacks 14 amino acids from its C-terminus 
(Kristin Pogoda). 
3. HeLadel296 express GFP-tagged Cx37 which lacks 37 amino acids from its C-terminus 
(Kristin Pogoda). 
4. HeLaY332A express GFP-tagged Cx37 which carries a mutation at position 332 where a 
tyrosine (Y) was changed to an alanine (A) (Kristin Pogoda).  
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Figure II-2 HeLa Cx37GFP DNA sequence using different colors for each sequence: N-terminus (black), 4 transmembrane 
domains (yellow), 2 extracellular loops (blue), a cytoplasmic loop (purple), C-terminus (red) and GFP (green). Gray is the DNA 
spacer. 
 
 
Figure II-3 Polypeptide sequence of Cx37GFP. The same colors were used for the polypeptide sequence as in the previous 
picture. 
 
Figure II-4 depicts a schematic representation of Cx37GFP and variants using different 
colors for each domain: N-terminus (black), 4 transmembrane domains (yellow), 2 extracellular 
loops (blue), a cytoplasmic loop (purple), C-terminus (red) and GFP (green). In variant Y332A 
the point mutation located at position 332 is marked in red, del319 lacking last 14 aa is marked in 
dark green and del296 lacking 14 aa is marked in purple. The same colors were used for the DNA 
and polypeptide sequence. 
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Figure II-4 Schematic representation of Cx37 and Cx37 mutants tagged with GFP at C-terminus 
II.3.1.3 Cell freezing and thawing 
For freezing, HeLa cells were detached after incubation with trypsin for 2 to 5 minutes, 
centrifuged (to remove the trypsin) and the cell pellet was suspended in an appropriate amount of 
freezing medium (FCS and 10 % DMSO). Afterwards, cell solutions were transferred to 
cryovials, frozen for 24 hours at -80°C and thereafter stored for preservation in liquid nitrogen (-
196°C). 
For thawing, the cryovials were transferred from liquid nitrogen to 37°C. After 5 minutes, 
the cell suspension was transferred from the cryovials in a tube with fresh cell culture medium 
and centrifuged at 1050 rounds per minute (rpm) for 10 min to remove the DMSO. The cell pellet 
was suspended in specific medium for each type of HeLa cells, plated in culture dishes and 
placed in the incubator (37°C and 5 % CO2). After 24 hours, cells were subcultured and used for 
experiments. 
II.3.2 Sample preparation and treatment of cells 
One day before experiments cells were seeded onto glass coverslips (13 mm diameter, coated 
with collagen I (10 µg/ml), and placed in a 24 well plate) or on 10 cm Petri dishes with the 
specific medium for each type of cells. For each condition the density of the cells allowed them 
to reach 80 % confluence the next day. At the next day the 24 well plates were rinsed twice with 
PBS+ and further processed for immunofluorescence assays and calcium measurements. For 
immunoprecipitation with GFP beads and Western Blot experiments the cells cultured on the 10 
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cm Petri dishes were washed two times with PBS+ and incubated with different substance as 
presented in Table II-1. Afterwards, the cells cultured on the 10 cm Petri dishes (see Figure II-5) 
were detached with trypsin, centrifuged to remove trypsin and the cell pellet was used for further 
experiments: 1) SDS buffer was added to samples for Western Blots; 2) immunoprecipitation 
with GFP nanobeads and 3) Protein S-nitrosylation. 
Table II-1 Tabel for substances used for treatment of the cells 
 
 
 
Figure II-5. Schematic representation for sample preparation for experiments 
 
Substance Concentration used  Solution  Incubation time 
SNAP 2 µM, 0.2 µM, 20 µM Hepes++ 20 min 
SNAP + orthovanadate 2 µM SNAP, 100µM orthovanadate Hepes++ 20 min 
genistein 100 µM Hepes++ 15 min 
orthovanadate 100 µM Hepes++ 15 min 
pH 6,6   Hepes++ 15 min 
H2O2 100 µM PBS+ 15 min 
suramin 50 µM Hepes++ 20 min 
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II.3.3 Polymerase Chain Reaction  
II.3.3.1 Isolation of total RNA 
Total RNA from cells was isolated using the RNeasy Mini Kit according to the 
manufacturer instructions. 1x106 cells were lysed in RLT buffer (denaturing guanidine-
thiocyanate containing buffer with 10 µl/ml ß-mercaptoethanol). QIAshredder columns were 
used to homogenize the samples (centrifugation 2 minutes at maximum speed). To assure a good 
binding, ethanol was added before the samples were loaded into the RNeasy Mini spin columns. 
RNA bound to the column and the contaminants were removed in a centrifugation step of 
10,000xg. Total RNA was eluted in an amount of 30 - 50 ul RNase free water and concentration 
was determined using a spectrophotometer. The samples were stored at -20oC and used for 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR). 
II.3.3.2 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
A Titan One Tube RT-PCR Kit was used to perform the reverse transcription and PCR in 
one step (all experiments were done according to the manufacturer`s protocol). This advanced 
system allows the conversion of RNA messages into amplified DNA fragments. Table II.1.4 
contains the primers sequences, which were designed with software primer 3 (Rozen & 
Skaletsky, 2000).  
Primers were diluted in ribonuclease (RNAse) free water (10 pmol/ul) and the ribonucleic 
acid (RNA) samples were placed on ice. In the meantime the mix containing: water (H2O), 
deoxyribonucleotide triphosphates (DNTP), dithiothreitol (DTT), 5xBuffer and RNase inhibitor 
was prepared. Subsequently, the mix, primers, template and enzyme mix were added in each 
reaction tub. Single steps and the temperature profile are listed in Table II-2. A Mastercycler was 
used for thermocycling.  
Table II-2 RT-PCR protocol with time, temperature and cycles used for each steps 
Time  Temperature Cycles Step 
30 min 50 oC  reverse transcription 
2 min 94 oC  denaturation template 
20 sec 94 oC 10 denaturation  
30 sec 55 oC 10 annealing 
45 sec 68 oC 10 elongation 
20 sec 94 oC 35 denaturation  
30 sec 55 oC 35 annealing 
2 min(+15 sec/cycle) 68 oC 35 elongation 
7 min 68 oC  longer elongation 
 
II.3.3.3  Agarose gel electrophoresis 
RT-PCR fragments were separated using 1 % agarose gel electrophoresis. Tris-borate-
EDTA (TBE) buffer and 1 % agarose were mixed and boiled in a microwave oven 2-3 min until 
the agarose was dissolved. The solution was cooled to 40 - 50oC and then Gel Red was added. 
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The 1 % gel was casted in a gel tray and cooled at room temperature to solidify for 1 hour. The 
samples were diluted with loading buffer (ratio 1:6) and were loaded along with a DNA size 
marker (1kb gene) in the gel pockets. Electrophoresis was performed at 100 Volts (V) for 
separation of the fragments. The fluorescence of PCR fragments was observed under UV light 
with Gel Doc 1000 station (Bio-Rad). 
 
II.3.4  Protein biochemistry 
II.3.4.1 Immunoprecipitation with GFP nanobeads 
GFP-Trap A nanobeads were used to immunoprecipitate Cx37GFP. Small GFP-binding 
proteins were coupled to agarose beads (GFP-Trap A), and used to pull down the Cxs tagged 
with GFP at their C-terminus (Figure II-6). 
 
Figure II-6 Schematic representation of Cx37 pull down with GFP Trap A nanobeads (Picture taken from ChromoTek) 
Cells were lysed for 30 min in 200 µl RIPA buffer supplemented with inhibitors (1 mM 
phenylmethylsulfonyl fluoride (PMSF), 1x Protein inhibitor Cocktail) extensively pipetting every 
10 min. After centrifugation of the input samples, 50 µl of the supernatant was mixed with 50 µl 
4xLaemmli buffer (Laemmli, 1970) and the supernatant was incubated with equilibrated GFP-
Trap A beads for 2 hours at 4oC. Cell lysates incubated with the GFP Trap A beads were 
centrifuged and for non-bound samples, 50 µl of the supernatant were mixed with 50 µl 
4xLaemmli buffer. The pellet containing beads bound to GFP-tagged Cx37 was washed with 
washing buffer to remove the unspecific binding. To elute Cx37GFP from the beads, the pellet 
was suspended in 100 µl 2xLaemmli buffer and boiled at 950C for 10 min followed by a 
centrifugation step. The supernatant containing Cx37GFP (without the beads) and non-bound 
(eluted) beads were loaded in 10 % acrylamide gel. 
II.3.4.2 Western Blot 
For detection of specific proteins extracted from cells Western Blots were performed. The 
procedure relied on: 1) the separation of protein mixtures by size using gel electrophoresis (SDS-
Page); 2) the efficient transfer of separated proteins to a solid support (semi-dry blotting); and 3) 
the detection of target proteins by specific antibodies, visualized as a band on a blotting 
membrane (detection). 
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1. SDS-Polyacrylamid gel electrophoresis (SDS-PAGE) 
Before loading, the lysed samples were boiled at 95oC for 10 min. The polyacrylamide 
gels 10 % (range for protein size 15-100 kDa) were placed in the tank with electrophoresis buffer 
and samples were loaded. A molecular weight marker with colored marker in red at 70 kDa was 
added to each gel to determine the relative molecular mass of the proteins (Table II-3). The gels 
ran at 185 V, 60 mA. 
Table II-3 The molecular weight of the protein  
Protein Protein size(kDa) 
HeLa Cx37  37 
HeLaCx37GFP 65 
HeLa Cx37GFP del319 63 
HeLaCx37GFP del296 60 
HeLaCx37GFP Y332A 65 
 
After SDS-Page, the gel was stained with Coomassie brillant blue staining solution and 
bands were cut from the gel for mass spectrometry analysis or continued with semi-dry blotting 
to detect the protein bands. The polyacrylamide gels were incubated for 1 hour under agitation in 
Coomassie brillant blue staining solution and then destained with 10 % acetic acid under 
agitation; thereafter only the blue protein bands were visible. 
2. Semi-dry blotting 
Semi-dry blotting was performed to transfer the proteins from the polyacrylamide gel to a 
nitrocellulose membrane. Membrane and filter paper were soaked in transfer buffer and then 
placed on the custom-made blotting unit (the gel and membrane were placed between two sheets 
of blotting paper) and set to 300 V for 80 – 100 min. After semi-dry blotting, the membrane was 
incubated 1 hour with 5 % nonfat dried milk powder in Tris buffered saline Tween (TBS-Tween 
/TBS-T) under gentile agitation at room temperature to block non-specific binding. 
3. Detection  
Incubation with primary antibodies was done (diluted 1:1000 µl in 5 % milk powder in 
TBS-T) on a shaker at 4oC overnight (Table II.1.3). The first antibodies were removed and the 
membranes were washed for 5 minutes in TBS-T buffer. Subsequently, the membranes were 
incubated at room temperature for 1 hour under gentile agitation with secondary antibodies. After 
10 minutes washing, the detection of the proteins was done with the Chemiluminescence 
Detection Kit for Horseradish Peroxidase (luminol-based substrate). To visualize the protein 
luminescent bands a digital CCD Camera connected to a computer equipped with the Wasabi 
imaging software was used. 
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Membrane stripping 
The stripping method was used to remove primary and secondary antibodies from the 
western blot membrane to be able to incubate the membrane with other antibodies. The 
membrane was incubated with western blot stripping buffer for 15 min at 37oC. After washing 
with TBS-T, the membrane was blocked 1 h with 5 % milk powder in TBS-T and then incubated 
with different primary antibodies. 
II.3.4.3 Protein S-nitrosylation  
After incubation of Cx37GFP cell lysates with GFP beads the samples were used for 
protein S-nitrosylation detection. The experiments were performed according to the kit protocol. 
In short: The first incubation step was performed with 500 µl buffer A containing blocking 
reagent under gentle agitation for 30 minutes at 4°C and then centrifuged for 10 minutes at 4°C at 
3.000xg. The second incubation step was done with 4 times the volume of ice-cold acetone for 
each sample at -20°C for 1 hour. Subsequently, samples were centrifuged at 3.000xg for 10 min 
at 4°C and then each protein pellet was incubated with 500 µl buffer B containing reducing and 
labeling reagents for 1 hour at room temperature. Afterwards samples were mixed by inversion 
with 4 times the volume of ice-cold acetone for each sample followed by incubation at -20°C for 
1 hour and centrifugation at 3.000xg for 10 min at 4°C. Samples were suspended in 100 µl 
washing buffer and then all samples were used for SDS-PAGE. The membrane was blocked with 
2 % BSA (to avoid high background signal) for 1 hour followed by incubation with S-
Nitrosylation detection reagent for 1 hour under gently agitation at room temperature (Figure II-
7). 
 
Figure II-7 Diagram of the three-step process of protein nitrosothiol derivitization with biotin (Picture taken from Cayman). 
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II.3.5  LC-MS/MS (Tandem mass spectrometry) Protein Identification 
Experiments were performed in collaboration with Prof. Axel Imhof´s group from the ZfP 
Munich. Samples were prepared in our laboratory and then sent to their laboratory for mass 
spectrometry analysis. Mass spectrometry steps were: 1) extraction, fractionation and/or 
enrichment of protein and/or proteolytically derived peptide mixtures, 2) peptide separation and 
ionization, 3) measurement and collection of mass spectra and 4) analysis of the obtained data. 
After pulldown of Cx37 using anti-GFP agarose beads, proteins were either separated on 
a SDS-PAGE gel (fractionated) or digested directly from the beads using different sets of 
proteases (in a first step) (Shevchenko, Tomas, Havlis, Olsen, & Mann, 2006). Proteins were 
enriched from two biological conditions: control cells and SNAP-treated cells. 
II.3.5.1 In gel digestion 
Individual protein bands were excised from Comassie briliant blue stained gels and sent 
for LC-MS/MS analysis. For “in gel” digestion excised protein bands were cut into smaller 
pieces to facilitate the efficient entering of reagents and enzymes. After several processing steps, 
the resulting peptide solution was evaporated in a speed vac device. For analysis by LC-MS/MS 
dried peptide samples were redissolved in 15 µl of 10 % trifluoroacetic acid (TFA) solution. The 
enzymes used to digest the gel bands were trypsin, chymotrypsin, GluC (Promega, USA) and 
LysC (Wako Chemicals, Japan) 
LC-MS/MS analysis of “in gel” digested samples 
Peptide samples were injected into the HPLC system and processed. Peptides eluting 
from the column were immediately ionized in the ionization source and detected by the LTQ 
OrbitrapXL hybrid mass spectrometer in the mass range from 300-2000 m/z and analysed for 
their charge state. Only the 6 most intense signals with charge state 2+ or higher were selected for 
fragmentation analysis. Peptide fragmentation was carried out using CID activation and 
generated peptide fragment ions were detected in the ion trap. All raw data were searched against 
a database containing the human proteome within the MASCOT search algorithm and peptide 
identification with a MASCOT score of 30 or higher were accepted (Table II-4). 
Table II-4 Parameters for MASCOT database search DBMIX  
Parameter MASCOT 
Mass error (precursor) 10 ppM 
Mass error (fragments) 0.5 Da 
Enzyme settings Trypsin/P ( trypsic cleaveage after K or R except they are followed 
by a P) 
Static modification Carbamidomethylation (C) 
Variable/dynamic modifications Oxidation (M) 
Phosphorylation (S,T,Y) 
Missed cleavages 2 
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FDR rate estimation Manual based on score settings 
No search against reversed database score ≥ γ0 
 
II.3.5.2 In solution digestion 
 The second method of samples digestion was performed directly on the beads (Cx37 
bound to GFP beads) without SDS-PAGE separation and included a step for peptide separation 
on a nanoscale reversed phase (RP) chromatography prior to mass spectrometry analysis 
(followed by ionisation of the eluting peptides using electrospray ionization, the peptide ions 
were transferred then directly into the vacuum of the mass spectrometer). For analysis of 
phosphorylated peptides, a TiO2-based solid-phase extraction step was introduced. Finally, the 
samples were injected into the HPLC for LC-MS/MS analysis. 
II.3.5.3 LC-MS/MS analysis 
The mass and signal intensity of peptides were measured in MS mode of MS instrument 
and the peptide fragments were detected in MS/MS mode after peptides were fragmented in ions. 
The raw data were searched within the Sequest and Andromeda search engines against the 
complete human database (IPI) to test analysis of digests. Phosphopeptides were first identified 
from a small database containing ~175 entries of human proteins, contaminants and the GFP-
tagged Cx37 sequence using Sequest and Maxquant search algorithms. Sequest identified the 4+ 
and 5+ charge states of the peptide with high confidence in the control and SNAP treated sample. 
MaxQuant succeeded to identify the 5+ charge state in the SNAP sample. The MASCOT search 
engine was not able to identify any phosphorylation in Cx37 which might be due to the high 
charge state of the precursor ion (4+ and 5+). (Table II-5) 
Table II-5 Database search settings: 
Parameters Sequest MaxQuant 
Mass error (precursor) 20 ppM 20 ppM for first search 
6 ppm for main search 
Mass error (fragments) 0.6 Da 0.6 Da 
Enzyme settings Trypsin or 
LysC/GluC combination 
Both fully specific 
Trypsin or 
LysC/GluC combination 
Both fully specific 
Static modification Carbamidomethylation (C) Carbamidomethylation (C) 
Variable modifications Oxidation (M) 
Phosphorylation (STY) 
Acetylation (Protein N-term) 
Oxidation (M) 
Phosphorylation (STY) 
Acetylation (Protein N-term) 
Missed cleavages 2 3 
FDR rate estimation Manual based on score settings 
No search against reversed database 
Automatic by search against 
reversed database  
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 Charge / minimal score 
2+ / 2.00 
3+ / 2.25 
4+ / 2.5 
5+ / 2.75 
6+ / 3.00 
 
 
 
Figure II-8 Identified peptides (underlined) in HeLa Cx37GFP cell lysate using Maldi Toff analysis. 
 
II.3.6 Immunofluorescence staining 
To visualize the localization of the protein and co-localization with GFP, the 
immunofluorescence technique was used. Cells were fixed 20 min with 3 % formaldehyde in 
PBS+, followed by two washing steps with PBS+. Afterwards the cells were permeabilized for 5 
min with 0.1 % TritonX-100 in PBS+, then washed twice with PBS+ and incubated with 1 % 
BSA in PBS+ for 1 h at room temperature to block unspecific protein binding sites. The 
incubation step of the cells with primary antibodies (Cx37 or GFP Ab) diluted in 0.2 % BSA in 
PBS+ was performed overnight at 4°C. The next day, the cells were washed at least 3 times 
followed by 1 h incubation (in the dark) with Alexa Fluor 546-coupled secondary antibodies, 
diluted 1:200 in 0.2 % BSA in PBS+. For negative control only, the secondary antibody was 
added to the cells. The coverslips were then transferred to a chamber and a few drops of PBS+ 
were added. The localization of Cxs was analysed by using the confocal laser scanning 
microscope Leica TCS SP 5 equipped with a 63x lens (NA 1.4 oil). Connexins tagged with GFP 
were analysed at an excitation wave length of 488 nanometer (nm) and 543 nm. The pinhole was 
set to 1-2 mm. The sample was scanned with a point illumination by a laser and the fluorescence 
from the focal plane was collected with a photomultiplier tube at the emission maxima of 515 nm 
and 570 nm respectively. 
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II.3.7  Calcium measurements  
Functional coupling was analysed using the Fura-2 AM staining, the mechanical 
stimulation method and a calcium measurement system. 
II.3.7.1 Staining  
To monitor and measure the intracellular Ca2+ concentration, a synthetic fluorescent 
indicator Fura-2 AM was used for staining the HeLa cells. The absorption of Fura-2 shifts 
depending on the Ca2+ concentration which is detectable by alternately exciting the dye at 340nm 
or 380 nm and observing the emission at 510 nm (Figure II-9). The ratio of fluorescence at 
340/380 nm is proportional to the concentration of free intracellular Ca2+. 
 
Figure II-9 The 340nm and 380nm wavelengths are highlighted to show typical responses of Fura-2 dye 
(http://www.wpiinc.com/blog/6) 
Fura 2-AM is a membrane permeable dye which is able to prevent hydrophilic carboxyl 
groups to form esters. Within the cells, the AM groups are cleaved by intracellular esterase 
enzymes and the dye is trapped inside and is able to bind calcium (Figure II-10) (Hirst, Harrison, 
Hirota, & Lambert, 1999). 
 
Figure II-10 Fura 2 binding Ca2+ after the AM groups were cleaved by esterases  
(http://www.dojindo.com/Images/Product%20Photo/F014_fig1.jpg) 
The coverslips with the cells were placed into the experimental chamber and were 
incubated with 4µM Fura 2-AM in Hepes at room temperature, in the dark, for 25 minutes. Cells 
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were washed with Hepes and then incubated with different substance according to the protocol 
used (see Table II-1). 
II.3.7.2 Mechanical stimulation 
After the cells were gently washed with HEPES the experimental chamber was mounted 
on the microscope table (MGW Lauda RM3), prior heated at 37oC. The temperature of the buffer, 
in the experimental chamber, was maintained constant during mechanical stimulation. All buffers 
and solutions were heated up to 37oC. 
One single cell was touched with a glass pipette (Zeiss puller diameter of the tip 1 µm) 
and moved with a micromanipulator (Eppendorf, Hamburg). Mechanical stimulation of one 
single cell produced an increase in intracellular calcium. The touching experiments were 
performed in HEPES buffer containing L-NA and SOD and potential ATP signals were blocked 
with the ATP-degrading enzyme Apyrase (50 U/ml) or the P2 receptor blocker suramin (50 µM) 
as indicated. In each well 3 touchings were performed in different areas. 
The touched cell was named initial cell (cell zero). Neighbouring cells with direct contact 
to the initial cell were named first ring and cells with direct contact to the cells from the first ring 
were named second ring (Figure II-11).  
 
Figure II-11 Schematic representation of mechanical stimulation of cells in first and second ring 
 
II.3.7.3  Calcium measurement  
Microscope 
Calcium measurements were performed using an inverted microscope (Axiovert, Zeiss, 
Germany) equipped with a camera (CCD, Imago, Till Photonics, Germany) and a light system 
(monochromator IV, Till Photonics), both controlled by a computer (TILLvisON, Till Photonics). 
Experiments were done with a 20x or 40 x lenses. 
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Excitation/Emission  
The stained cells within the visual area were excited at two alternating wavelengths (340 
nm and 380 nm) and the fluorescence signal was recorded at 505 nm every 250 ms for 50 s on the 
computer (movie 340 nm and movie 380 nm). 
 
Figure II-12 Microscope system used for Ca2+-imaging 
After each experiment, the signal was corrected for the background and the signal ratio 
was calculated by the software as follows: Ratio= (value movie 340nm-background)/ (value 
movie 380 nm-background). The ratio corresponds with the intracellular calcium signal over time 
(Bright, Fisher, Rogowska, & Taylor, 1989).  
Mean calcium concentration of single cells 
In the ratio movie, the program TILLvisON allowed marking the borders of each cell 
which then were converted in regions of interest (ROI) and the mean intracellular calcium signals 
of each cell were shown in kinetic graphs (Figure II-13). From this graph, the total number of 
cells within first and second ring as well as the number of cells showing a calcium increase 
within the first and second ring was counted. Finally, the percentage of cells that showed an 
increased calcium level (reacting cells) were calculated. Cells were counted as “reacting” when 
the calcium level increased by more than 0.025 (ratio, arbitrary units). 
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Figure II-13 Kinetics graph of several cells after mechanical stimulation 
 
II.3.8 Statistical Analysis 
 
Experiments were performed (n) times in different wells (w) using at least three different 
cultures (C). Statistical tests were performed using Origin version 8. For normally distributed 
data we used the t-test to compare two independent samples. In cases where data were not 
normally distributed we used the Mann – Whitney test instead. In the respective figures legends 
we indicated the test used. Statistical significance was defined as a p- value less than 0.05 
indicating an error probability of less than 5 %. Please note, that for reasons of comparability, all 
values are expressed as means ± standard error of the mean (SEM), although the non-parametric 
tests do not test for differences of means. 
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III. RESULTS 
III.1 Characterization of full length Cx37 expressed in HeLa Cx37GFP cells 
 
Expression of green fluorescent Cx37: 
Initially, cells that express exclusively Cx37 tagged with GFP at its C-terminus were 
created. HeLa cells were used as they do not express Cxs in the wild type form. The plasmids 
(Cx37GFP and several GFP tagged mutants) were transfected into HeLa cells and stably 
transfected cells were exhibiting a green fluorescence as indicated in Figure III-1. The left panel 
of Figure III-1 depicts a transmission and the right panel the corresponding fluorescence image of 
the HeLa Cx37GFP cells. In all analysed images, we observed about 90 % fluorescent cells. 
 
Figure III-1 Fluorescent HeLa Cx37GFP cells tagged with GFP at C-terminus HeLa Cx37GFP cells observed with a 
fluorescence microscope. The left panel represents the transmission image and the right panel represents the fluorescent image of 
the cells. 
 
III.1.1 Immunofluorescence staining of Cx37GFP in HeLa Cx37GFP cells 
 Additionally, the expression of Cx37GFP in the cells was validated by staining the cells 
with specific antibodies against Cx37 and then analyzing them using a confocal microscope. 
Figure III-2, depicts two cells (cell 1 and cell 2) showing the green fluorescence of GFP (left 
panel) and the red fluorescence due to specific Cx37 staining (middle panel) and for each one the 
nucleus (N) is distinct, as is not stained. The overlay of the two first panels is presented in the 
right panel and revealed the same localization of the Cx37 and the GFP in the HeLa Cx37GFP 
cells. Cx37 is mostly distributed within the membrane. 
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Figure III-2 GFP fluorescence and Cx37 staining showed the same location of Cx37 and GFP in membrane of the cells and 
also in the cytosol. The left panel represents the autofluorescence of GFP, the middle panel the staining with Cx37 Ab and the 
right panel the overlay of left and middle panels. The white arrows indicate the contact point between the cells. 
 
III.1.2 Western blot analysis of Cx37GFP  
Next, Cx37GFP expression was investigated using SDS-Polyacrylamid gel electrophoresis 
followed by Western Blot analysis. In HeLa cells expressing Cx37, the protein band was 
observed at 37 kDa (Figure III-3). Although Cx37GFP protein molecular mass should be 65 kDa 
(Cx37: 37kD and GFP: 28kDa), a lower double band was observed at 55kDa for HeLa Cx37GFP 
cells (Figure III-3). The experiments were performed several times with different protocols and 
protein kinase inhibitors were used to stop the protein degradation. In all experiments we found 
the 55kDa bands.  
 
Figure III-3 Cx37 protein expression in HeLa Cx37 (H37) and Cx37GFP (H37GFP) cells with Ab Cx37. The Western Blot 
showed for control cells HeLa Cx37 a protein band at 37kDa and for HeLa Cx37GFP a band at 55kDa. The antibody used was 
Cx37. 
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III.1.3 mRNA expression of Cx37GFP  
For analysis of the mRNA expression of Cx37GFP RT-PCR experiments were performed 
using specific primers for Cx37 and GFP. Primers were designed as following: one set of two 
primers for a fragment of Cx37 (forward primer starting at base 212 and ending at 231; reverse 
(rev) primer starting at 499 and stopping at 480) and another set of two for the whole GFP 
(forward primer starting at 1051 and ending at 1068; reverse primer starting at 1791 and ending 
at 1774) and Cx37 forward and GFP reverse primers were used for Cx37GFP fragment. To 
evaluate the length of the RNA molecule we used base pairs (bp) which are pairs of nucleotides 
joined with a hydrogen bound found in RNA. HeLa Cx37 cells served as positive control for the 
Cx37 band (see black arrow size 288bp) and HeLa Cx43GFP as positive control for the GFP 
band (see black arrow size 741bp). As negative controls HeLa Cx37 (with primer for GFP 
fragment and Cx37 forward primer and GFP reverse primer, see orange arrows), HeLa Cx43GFP 
with primer for Cx37 fragment (see green arrow) and HeLa Cx37GFP (with Cx43 primer and 
Cx43 forward primer and GFP reverse primer, see blue arrows) were used. In negative controls, 
no RT-PCR bands could be observed. In HeLa Cx37GFP cells three RT-PCR products were 
observed one at 288bp for Cx37 (indicated with a black arrow) and second product at 741bp for 
GFP (indicated with a black arrow), which corresponded with the size of RT-PCR products from 
control cells HeLa Cx37 and HeLa Cx43GFP (indicated with a black arrow). The 1580bp (black 
arrow) was obtained with Cx37 forward primer (For_1Cx37) and GFP reverse (gfp-rev) (see 
Figure III-4).  
 
Figure III-4 RT-PCR products in HeLa Cx37GFP, HeLaCx37 and HeLa Cx43GFP cells. Control cells used are HeLa Cx37 
and HeLa Cx43GFP. Primer for Cx37 showed in HeLa Cx37GFP and HeLa Cx37 cells a 288bp band and primer for GFP a band 
at 741bp for HeLa Cx37GFP and Cx43GFP cells. The band at 1580bp was observed in HeLa Cx37GFP cells when primer for 
Cx37 and GFP primer were used.  
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III.1.4 HeLa Cx37GFP coupling 
To further investigate the permeability of the GJs built by Cx37GFP, calcium 
measurements in HeLa Cx37GFP cells were performed. Figure III-5 indicates the schematic 
representation of HeLa Cx37GFP cell coupling defined as the transfer of a calcium signal via gap 
junctions from the initially stimulated cell to the neighbouring cells. Cells were mechanically 
stimulated to show that HeLa expressing Cx37GFP were functionally coupled. 
 
Figure III-5 Schematic representation of mechanical stimulation of HeLa Cx37GFP cells. Mechanical stimulation of one cell 
led to an increased concentration of calcium. The calcium signal spread via GJ to the neighbouring cells. 
Coupling of HeLa Cx37GFP can be observed in Figure III-6. The calcium concentration 
(ratio 340nm /380nm) of cells before stimulation (A) is shown in blue indicating low 
concentration of intracellular calcium. Mechanical stimulation (B) led to an increase of calcium 
concentration in the stimulated cell. With a short time delay (2 sec), the calcium signal 
propagated via gap junctions to neighbouring cells leading to a calcium increase in these cells 
(C/D). 
 
Figure III-6 Coupling of HeLa Cx37GFP cells using mechanical stimulation. Panel A representative ratio of the cells after 
staining with Fura 2 AM before mechanical stimulation (blue low calcium), the panel B indicates the initial cell stimulated with 
increased calcium concentration, the panel C and D show the spreading of the calcium signal via GJ to the neighbouring cells. 
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III.1.5 The effect of different concentrations of SNAP on HeLa cells  
The relationship between the SNAP concentration and the cell response was analysed and 
the dose response curve is shown for different concentrations of SNAP: 0 µM, 0,2 µM, 2 µM, 20 
µM, 200 µM (Figure III-7). The potential effect of ATP released due to mechanical stimulation 
was blocked by inhibition of the P2X receptors (50 µM suramin). Under control conditions (0 
µM SNAP) HeLaCx37GFP exhibit a GJ coupling of 50±4 % (n=29, w=18, C=4). SNAP 
treatment reduced GJ coupling (see Figure III-7) as follows: treatment with 0,2 µM SNAP 
reduced the coupling to 46±5 % (n=17, w=14, C=5), 2 µM SNAP to 30±8 % (n=12,w=10, C=5), 
20 µM SNAP to 17±5 % (n=12, w=12, C=4) and 200 µM SNAP to 16±4 % (n=16, w=7, C=3). 
Incubation of HeLa Cx37GFP cells with various concentrations of SNAP revealed that 2µM 
SNAP reduced GJ coupling by 40 % and in all following experiments we used this concentration 
of SNAP. 
 
Figure III-7 The concentration dependent effect of 0,2 µM, 2 µM, 20 µM, 200 µM SNAP in HeLa Cx37GFP cells. All 
experiments were performed using 50 µM suramin and different concentrations of SNAP (0µM SNAP, 0,2 µM SNAP, 2 µM 
SNAP, 20 µM SNAP and 200 µM SNAP). GJ coupling was reduced by NO treatment compared with GJ coupling in control. 
 
III.1.6  The effect of SNAP, pH 6.6 and H2O2 on -Cx37GFP coupling 
HeLa Cx37GFP cells were treated with 2 µM SNAP, a Hepes solution of pH 6,6 and 
100mM H2O2. Figure III-8 A shows that treatment with 2 µM SNAP reduced the number of 
neighbouring cells showing an increased calcium signal upon mechanical stimulation from 47±5 
% (n=25, w=11, C=4 (control) to 23±3 % (n=25, w=11, C=4). At a pH of 7.4 (control) 57±6 % 
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(n=9, w=5, C=4) of the cells reacted after stimulation whereas at a pH of 6.6 the coupling was 
reduced to 30±5 % (n=6, w=3, C=2) (Figure III-8 B). Figure III-8 C depicts that coupling of the 
cells is reduced from 68±8 % (n=11, w=5, C=3) to 23±7 % (n=22, w=10, C=4) after treatment 
with 100 mM H2O2.  
 
Figure III-8 Functionality of HeLa Cx37GFP cells under control and treatment conditions. A. SNAP reduced the number of 
reacting cells to 24±3 % (n=25, w=11,C=4) compared to control 47±5 % (n=25, w=11, C=4, t-test); B. For pH 7.4 the GJ 
coupling is at 57±6 % ( n=9, w=5, C=4) whereas for pH 6.6 is reduced to 30±5 % (n=6, w=3, C=2, t-test); C. Treatment with 
100mM H2O2 decreased the GJ coupling to 23±7 % (n=22, w=10, C=4) versus control 68±8 % (n=11, w=5, C=3, Mann – 
Whitney test)  
 
III.1.7 The effect of genistein and orthovanadate on Cx37 coupling 
To analyse whether tyrosine phosphatases and tyrosine kinases could be involved in post- 
translational modifications pathways experiments were performed with 100 µM orthovanadate 
(OV, tyrosine phosphatases inhibitor) and 100 µM genistein (tyrosine kinase inhibitor) to study 
their effects on intercellular communication. Treatment with 100 µM orthovanadate did not affect 
GJ coupling (con: 81±3 %, n=24, w=9, C=4; OV 87±3 %, n=23, w=8, C=4 Figure III-9 A). 
However, after preincubation of the cells with orthovanadate NO had no further effect on 
intercellular calcium signaling (100 µM orthovanadate and 2µM SNAP: 84±3 %; n=19, w=6, 
C=3). Figure III-9 B shows experiments with genistein treated cells. Genistein reduced the GJ 
coupling to 61±5 % (n=27, w=9, C=3) versus control 81±4 % (n=25, w=10, C=3). As OV 
inhibits all tyrosine phosphatases and genistein all tyrosine kinases which are acting on several 
tyrosine residues within the connexin, these effects could be the summation of several single 
effects. 
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Figure III-9. Effect of genistein and orthovanadate on GJ coupling in HeLa Cx37GFP cells. A despicts the effect of 
orthovanadate on GJ coupling versus control conditions (n=23, w=8, C=4, one way ANOVA – on ranks). After treatment with 
orthovanadate SNAP had no further effect on intercellular calcium signaling. B genistein treatment reduced the GJ coupling 
(Mann – Whitney test). 
 
III.1.8 Analysis of posttranslational modifications of Cx37GFP induced by NO 
Several posttranslational modifications of Cx37 (e.g. phosphorylation, nitration) could be 
induced by NO. To identify the possible post-translational modification and the site of the 
modifications we used Western Blot, S-nitrosylation and mass spectrometry analysis. 
III.1.8.1 Identification of S-nitrosylated Cx37GFP protein 
To reveal other posttranslational modifications like S-nitrosylations, a S-nitrosylation 
assay was performed with control- and NO- (2 µM SNAP) samples. Western blot experiments 
revealed several identical bands of S-nitrosylated Cx37 in control and SNAP HeLa Cx37GFP cell 
lysates samples, consequently samples were prepared with two different protocols, as described 
below: 
1. GFP beads pull down of Cx37GFP followed by S nitrosylation assay and  
2. The S nitrosylation method followed by the pull down of the Cx37 with GFP nanobeads. 
Both protocols showed bands at the same size for SNAP samples whereas in control 
samples no bands were observed. 
RESULTS 
 
42 
 
 
Figure III-10 S-nitrosylation assay in HeLa Cx37GFP cells in control and treatment conditions  
III.1.8.2 Mass spectrometry 
Posttranslational modifications can be analysed by mass spectrometry. Initially, the 
protein was identified in HeLa Cx37GFP cells and afterwards the specific modifications induced 
by NO were analysed. 
To identify the Cx37 protein in HeLa Cx37GFP cells, GFP nanobeads pull down was 
performed and the samples were analysed with mass spectrometry. Figure III-11 depicts the 
schematically drawing of the transmembrane protein Cx37 with: with the corresponding peptide 
sequences in the right panel. The Mass spectrometry analysis identified three peptides in the 
Cx37 samples: one in the extracellular loop - APCPHIVDCYVSRPTEK (see blue arrow) - one in 
C-terminus - LTSSRPPPFVNTAPQGGRK (see red arrow) - and one in GFP tag - 
EDGNILGHKLEYNYNSHNVYIMADK (see green arrow). Mass spectrometry analysis 
revealed the presence of the Cx37 in HeLa Cx37GFP cells.  
 
 
Figure III-11. Identified peptide in HeLa Cx37GFP cell lysate using Maldi Toff analysis 
Further mass spectrometry analysis was performed with control- and NO- samples to 
localize the specific site for the modification. Several experiments were performed using different 
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amounts of the Cx37 protein. Also, for a better identification of the possible modification site, 
different types of enzymes were used in mass spectrometry analysis. Unfortunately, the 
identification of modifications at the C-terminus of Cx37 was difficult as all enzymes cleaved the 
C-terminus at sites, making the analysis of the last 20 aa present in the C-terminus impossible. 
Due to this difficulty the analysis of Cx37 C-terminus with a possible site specific for 
posttranslational modifications could not be performed. 
 
III.2 Characterization of Cx37GFP variants in HeLadel319 and HeLadel296 
cells 
III.2.1 Immunofluorescence staining of del319 and del296 in HeLadel319 and 
HeLadel296 cells 
The expression of del319 and del296 in the cells was validated by immunofluorescence 
staining with Cx37 Ab using a confocal microscope. Figure III-12, depicts two cells (cell 1 and 2) 
each one showing an unstained distinct nucleus (N) and stained Cx37 at the contacts is the cells 
indicated by the arrow. The left panel shows the green fluorescence of GFP and the middle panel 
reveals Cx37 staining in red. The right panel depicts the overlay (yellow) of GFP fluorescence 
and Cx37 stained with the specific Ab. The overlay revealed the same location of GFP and Cx37 
within the membrane of Cx37 mutant del319 and del296. 
 
Figure III-12 Immunofluorescence staining revealed the same location of the GFP tag and Cx37 in the cells. The left panel 
represents the autofluorescence of GFP, the middle panel the staining with Cx37 Ab and the right panel the overlay of left and 
middle panels. The white arrows indicate the contact point between the cells. 
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III.2.2 Western Blot analysis of del319 and del296  
SDS-Polyacrylamid gel electrophoresis followed by Western Blot analysis was used to 
observe the expression of del319 and del296 expression in corresponding cells. Figure III-13 
depicts two Western Blots using specific antibodies (Abs) against GFP (Ab GFP, left blot) and 
Cx37 (Ab Cx37, right blot). For HeLadel319 a band at 63 kDa was observed and for HeLadel296 
a band at 60 kDa was observed (black arrows Figure III-13). 
 
Figure III-13 del319 and del296 protein expression in HeLadel319 and HeLadel296 cells detected with Abs against Cx37 
and GFP. The left blot with GFP Ab depicts the same bands as the right blot with the Cx37 Ab for del319 at 63 kDa and for 
del296 at 60 kDa. 
III.2.3 mRNA expression of del319 and del296 mutants 
The mRNA expression of the mutants was performed with the same primers used for 
Cx37GFP. In HeLadel319 and del296 cells three RT-PCR products were observed, one product 
at 741bp for GFP (indicated with a black arrow), one product at 288bp for Cx37 (indicated with a 
black arrow) and one product at 1580bp (part Cx37 and full GFP, indicated with a black arrow in 
Figure III-14). RT-PCR products observed in both mutants corresponded with the band size from 
control HeLa Cx37-, HeLa Cx43GFP- and also HeLa Cx37GFP-cells (see Figure III-4). 
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Figure III-14 RT-PCR products observed in HeLadel319 and HeLadel296 cells. HeLadel 319 and HeLadel296 revealed RT-
PCR products at 288bp for Cx37, 741bp for GFP and 1580bp for part of Cx37 and full GFP. Similar products were observed in 
HeLa Cx37GFP cells. 
III.2.4 Coupling of HeLadel319 and del296 cells and NO effect on mutants 
The permeability of the GJs built by the Cx37 mutants del319 and del296 was analysed 
by detection of the intercellular calcium signaling induced by mechanical stimulation. Figure III-
15 depicts that HeLadel296 and HeLadel319 could indeed form functional intact GJ channels. In 
non-treated HeLadel296 cells, calcium signal spread to 72±8 % (n=15, w=9, C=3) neighbouring 
cells, whereas HeLadel319 cells showed a lower number of coupled neighbouring cells (con: 
48±5 %, n=27, w=12, C=6, Figure III-15 B). In contrast to full length HeLaCx37GFP, treatment 
of these cells with 2µM SNAP did not affect the intercellular calcium signal spreading 
(HeLadel296: NO: 64±7 %, n=15, w=11, C=3; HeLadel319: NO: 52±5 %, n=27, w=10, C=5). 
The results – compared with the full length experiments – showed that the 2µM SNAP effect was 
abolished in the mutants. 
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Figure III-15 Intercellular calcium signal spreading in HeLadel296 and HeLadel319. A depicts GJ coupling in del296 
(Mann-Whitney test) and B depicts gap junction communication (GJC) in HeLadel319 cells(t-test). In both mutants, the SNAP 
effect on GJ coupling was no more observed. 
III.2.5 The effect of pH 6.6 and H2O2 on HeLadel319 coupling 
Furthermore, similarly as in full length Cx37-cells, experiments at a pH 6.6 and with 
100mM H2O2 were performed for mutant HeLadel319. Figure III-16 A shows that at a pH of 7.4 
58±8 % of the neighbouring cells were showing an increased calcium level upon stimulation. At 
a pH of 6.6 the GJ coupling was reduced to 24±7 % (n=14-16, w=7-9, C=3-5). In addition 
treatment with 100 mM H2O2 reduced GJ communication to 19±5 % versus control conditions 95 
% (n=15-20, w=6-7, C=3, Figure III-16 B).  
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Figure III-16 Calcium signal spreading in HeLadel319 cells treated with pH 6.6 and 100 mM H2O2. Intercellular coupling of 
HeLadel319 cells was reduced by low pH 6.6 (A, Mann-Whitney test) and H2O2 (B, Mann-Whitney test). 
III.2.6 The effect of genistein on HeLadel319 coupling 
Figure III-17 depicts that 100µM genistein (a tyrosine kinases inhibitor) reduced the GJ 
coupling in HeLadel319 from control 99 % (n=13-15, w=6, C=3) to 86±4 %. 
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Figure III-17 Effect of genistein on GJ coupling in HeLadel319. Del319 control showed 99 % GJ coupling and 100µM 
genistein treatment reduced the coupling to 86±4 % (Mann-Whitney test). 
 
III.3 Characterization of HeLaY332A cells 
III.3.1  Immunofluorescence staining of HeLaY332A 
Immunofluorescence assays were performed to analyse the localization of Y332A in the 
cells which was stably transfected in HeLa cells. Figure III-18 (left panel) depicts the localization 
of autofluorescent GFP which is found in the cytosol, in the cell membrane and also at the 
contact points between cells indicated by the arrow. The middle panel shows the 
immunohistochemical staining of GFP. The overlay picture (right panel) revealed the same 
location of GFP and mutant Cx37 in the plasma membrane of the cells (see white arrow). 
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Figure III-18 Representative image of the GFP autofluorescence and specific GFP staining in HeLaY332A cells. The left 
panel represents the GFP autofluorescence, the middle panel the GFP Ab staining and the right panel the overlay of the left and 
right panel. 
In addition, immunohistochemical analysis was also performed using Ab against Cx37 
(middle panel Figure III-19). When overlaid with the transmission picture (right panel), the same 
location of the Y332A protein and the autofluorescent GFP (left panel) was found. 
 
Figure III-19 Expression of Y332A in stably transfected HeLaY332A cells. The representative images show the 
autofluoresecence of GFP (left panel), immunhistochemical staining of Cx37 (the middle panel) and the overlay of both 
fluorescent images with the corresponding transmission image. The white arrows indicate the contact point between the cells. 
 
III.3.2 Western Blot analysis and mRNA expression of point mutation Y332A 
Figure III-20 depicts a Western Blot with HeLaY332A cells which revealed a protein 
band at 65 kDa. 
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Figure III-20 The western blot with Cx37 Ab depicts a band at 65 kDa for HeLaY332A  
In the next step, the mRNA was isolated from HeLaY332A and a RT-PCR was performed 
using the same primer as in experiments with other mutants. Figure III-21 depicts the RT-PCR 
gel with several bands: the left band at 741bp for the GFP part, the middle band at 288bp for the 
Cx37 and the right band for Cx37GFP at 1580bp (indicated by black arrows). All bands obtained 
had the same size as in full length Cx37GFP, mutant del319 and del296 cells. 
 
Figure III-21 RT-PCR products in HeLaY332A cells. The PCR products obtained from HeLaY332A had fragments with the 
size of 288 bp for Cx37, 741 bp for GFP and 1580bp for Cx37GFP. 
RESULTS 
 
51 
 
III.3.3 Coupling of HeLaY332A cells and the effect of SNAP, pH 6.6 and 100mM 
H2O2 on mutant Y332A 
The HeLaY332A cells expressing Cx37 with only one aa at position 332 exhibit a 
calcium signal transfer to 72±4 % of their neighbouring cells (n=14, w=5, C=2, Figure III-22 A). 
To test whether GJs formed by mutant Y332A could be blocked by SNAP or endogenous 
inhibitors the cells were incubated with 2 µM SNAP, pH 6.6 and 100 mM H2O2. 2 µM SNAP did 
not affect the intercellular communication (70±5 %, n=12, w=5, C=2) whereas pH 6.6 reduced 
the calcium signal transfer to 16±7 % (n=10, w=5, C=3) versus control pH 7.4 at 65±19 % (n=5, 
w=4, C=3; Fig. III-22 B). Figure III-22 C depicts that treatment with 100mM H2O2 showed a 
reduced calcium signal transfer at 10±5 % (n=11, w=4, C=2) compared with control (64±6 %, 
n=10, w=4, C=2). These results indicate that tyrosine at position 332 seems to be important for 
the mediation of the NO effect. 
 
Figure III-22 GJ coupling in HeLaY332A cells after treatment with SNAP, pH6,6 and H2O2. A. GJ coupling under control 
conditions and after SNAP treatment (t-test). B. pH 7.4 conditions showed 65±19 % GJ coupling compared with 16±7 % at a pH 
of 6.6 (Mann-Whitney test). C. GJ coupling in control cells and after 100mM H2O2 treatment (Mann-Whitney test). 
 
* * 
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III.3.4 Effect of genistein on the GJ coupling in HeLaY332A cells 
Finally, experiments with 100µM genistein were performed and revealed that genistein 
still reduced GJ communication from 81±6 % (con) to 50±6 % (genistein, n=11-14, w=5, C=3, 
Figure III-23).  
 
Figure III-23 GJ coupling of HeLaY332A cells treated with 100µM genistein. GJ communications was reduced after genistein 
treatment from 81±6 % to 50±6 % (t-test) 
. 
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IV. DISCUSSION 
 
In the present study we showed that Cx37GFP forms functionally intact GJs in HeLa 
cells, which allow the gap junctional calcium exchange to the same extent as wt-Cx37 do. The 
inhibitory effect of NO on the GJ calcium exchange, which is specific for Cx37, requires the 
presence of the last 19 aa in the C-terminus of Cx37 as assessed by the mutants del296 and 
del319. The lack of NO effects after conservative exchange of tyrosine 332 against alanine 
suggests that a NO mediated modification of this tyrosine forms the molecular basis of the NO 
mediated inhibition. This may be due to a change of tyrosine phosphorylation since the inhibitor 
of tyrosine phosphatases, orthovanadate, abolished the NO effect. 
Our studies were performed in HeLa cells since their natural connexin genes are silenced 
(Cao et al., 1998) so that they do not express Cxs anymore in the wild type form in contrast to 
normal epithelial cells. This allows to study the effects of a defined connexin and of homotypic 
and homomeric gap junctions. This is important since, although in general molecules with a mass 
of less than 1kDa (sugars, amino acids, nucleotides, vitamins, ions and non-biological 
substances) can diffuse via GJs into neighbouring cells (Berg, 2013), the permeability of GJs is 
not uniform. The relative unitary conductance, in picoSiemens (pS) for homotypic channels is 
Cx37 (300pS) > Cx40 (140pS)> Cx43(100pS) > Cx45(30pS) (Johnstone et al., 2009). Several 
groups showed that different Cxs have a selective permeability to ions metabolites, fluorescent 
dyes and second messengers (IP3, cAMP) (Elfgang et al., 1995; Weber, Chang, Spaeth, Nitsche, 
& Nicholson, 2004; Bedner et al., 2006). For example Cx43 have a high permeability for Alexa 
488 compared with Alexa 350 (Weber et al., 2004). Bedner et al. showed that Cx43 is more 
permeable to cAMP than other Cxs (Cx26, Cx45 and Cx32) (Bedner et al., 2006). Homotypic 
gap junctions may rarely exist in cells such as endothelium or smooth muscle cells, which usually 
express several types of Cxs that may form heterotypic and heteromeric gap junctions. As a 
consequence, different permeabilities and also different regulation of permeability may result 
(Ek-Vitorin & Burt, 2013). It is therefore important to use a cell model which allows studying a 
certain connexin or a certain combination of connexins. The inhibitory effect of Cx37 is still 
functionally present, when hemichannels formed by Cx37 are coupling with hemichannels 
formed by Cx43. We have shown before, that at least the coupling between HeLa cells which 
express Cx43 and Cx37 and thus form heterotypic (but homomeric) gap junctions are still 
inhibitory regulated by NO (Kameritsch et al., 2005).  
We have transfected HeLa cells with Cx37 and mutants of Cx37 which had been tagged 
with GFP. This GFP extended the C-terminus of Cx37. As already demonstrated by earlier 
findings of our laboratory, the addition of the GFP tag to Cx43 did neither affect its membrane 
distribution nor the channel functions of the respective gap junctions formed, as assessed by 
transfer of the small molecular dye calcein (J. Behrens, Kameritsch, Wallner, Pohl, & Pogoda, 
2010). Here we could now show that the addition of GFP to the Cx37 protein did also not affect 
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its membrane distribution or calcium permeability when compared to wt Cx37. This was also true 
for the mutants we have used. Thus, the modification with GFP did not functionally affect gap 
junctional coupling. Similar results were also reported by Kyle et al. who used transient 
transfected HeLa cells with GFP-tagged Cx37 to study the membrane distribution and 
permeability of mutations of the N-terminus (Kyle et al., 2008). These authors also report a 
functional channel formation with full length, GFP tagged Cx37 (Kyle et al., 2009). The tag 
allowed the use of GFP antibodies and GFP nanobeads for a better analysis of Cx37 and its 
mutants with regard to localization and expression. Expression of GFP tagged Cx37 has also 
been shown by Western blot using GFP antibodies. Cx37 showed a band at around 37 kDa (A. 
Harris, 2009). It its known, that GFP has 28 kDa and in our experiments cells revealed bands for 
Cx37GFP del319 at 63kDa, Cx37GFP del296 at 60 kDa and Cx37GFPY332A at 65 kDa. All 
mutants had size bands corresponding to their predicted molecular mass. Cx37GFP showed a 
band at 55 kDa which was lower than the expected value of 65 kDa. As the RT-PCR led to the 
correct DNA fragment and the connexins were inserted into the membrane forming functional 
gap junctions comparable to Cx37 we used the HeLaCx37GFP in our experiments despite the 
wrong size in the western blot.. GFP mutants of connexins were also shown to be functional. E.g. 
Hunter et al. used GFP tagged Cx43 in their experiments and they showed that GJ plaques were 
formed even if ZO-1 is not binding to Cx43-GFP (Hunter, Jourdan, & Gourdie, 2003). Breidert et 
al. used a GFP tagged Cx49 to observe the intracellular transport and traffic of Cx43-GFP. Their 
study provides new information about Cx transport to the plasma membrane, GJ formation and 
which elements could be involved in Cxs sorting and which proteins are involved in Cx folding 
(Breidert, Jacob, Ngezahayo, Kolb, & Naim, 2005). 
 In this study we assessed the gap junctional transfer of calcium or calcium releasing 
agents as derived from calcium increases in adjacent cells after mechanical stimulation of a single 
cell. Mechanical stimulation leads also to the release of ATP via hemichannels, which could also 
lead to calcium increases in neighbouring cells by acting on P2 receptors. This paracrine 
stimulation was excluded by treating the cells with a purinergic P2 receptor blocker, suramin 
(Hoyle, Knight, & Burnstock, 1990), which blocked the direct action of exogenously applied 
ATP up to a concentration above 10 µM. Indeed we did not observe a calcium increase in the 
neighbourhood of mechanically stimulated wt HeLa cells lacking connexins. This further 
supports our view, that the induction of calcium increases in neighbouring cells was GJ 
dependent and, therefore, a measure of gap junctional coupling and – indirectly – of their overall 
permeability. The mechanical stimulation of a single cell led to an increase in cytosolic calcium, 
probably due to an activation of some of its mechanosensitive calcium channels. Previous 
experiments of others and our own laboratory yielded evidence that the gap junctional transfer to 
adjacent cells involves calcium as well as IP3, the latter being important for eliciting calcium 
responses in remote cells (Kameritsch et al., 2012). Our experiments revealed that all mutants 
studied showed functional GJ coupling. The variations in the number of cells reacting did not 
indicate any systemic reduction of the gap junctional permeability to calcium in the mutant cells. 
It must be emphasized that the number of reacting cells is only an indirect measure of calcium 
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permeability of gap junctions and depends also on other variables such as the confluence of cells 
and local geometric conditions.  
Nevertheless, our experiments clearly showed that exogenous NO, as generated by the 
treatment with the NO donor SNAP (Kameritsch et al., 2005), showed a reproducible and highly 
significant reduction of gap junctional calcium transfer. This inhibitory effect was dose 
dependent. Previous calculations suggest that the standard dose used here may well relate to the 
high normal concentration range of NO that is achieved during pharmacologic endothelial cell 
stimulation. The treatments of cells with 1 µM SNAP correspond to a local concentration of 
about 2 nM NO (Ishida et al., 1996) therefore the NO used in experiments can be calculated to be 
around 100 pM up to approximately 5 nM as pointed out by Kameritsch et al. in their recent 
paper. This is a concentration range reached during endothelial cell stimulation (Hall & 
Garthwaite, 2009). 
We have shown before that NO also blocks the gap junctional transfer of molecules of 
higher mass such as Alexa Fluor 488, calcein or carboxyfluorescein (Kameritsch et al., 2005) 
suggesting that also the transfer of cyclic nucleotides which have a similar molecular mass and 
surface charge may be compromised. However, we have also shown before that the electrical 
coupling, which is carried by ions is not significantly affected by NO (Kameritsch et al., 2005) 
which can be explained by the relative concentrations of calcium as compared to other anions and 
cations such as chloride, potassium and sodium. Our observations are in line with others 
reporting NO inhibitory effects on Cx37 in microvascular endothelial cells (McKinnon et al., 
2009). In neuronal cells, GJ permeability was reduced by NO via cGMP (Rorig & Sutor, 1996) 
and similar results were observed in cardiac cells (Kwak & Jongsma, 1996). Vasoconstriction in 
mouse cremaster arterioles was diminished by NO (endogenous and exogenous) but involved 
other Cxs than Cx40 (Rodenwaldt, Pohl, & de Wit, 2007). Interestingly Pfenninger et al. 
demonstrated in EC an interaction between eNOS and Cx37 (Pfenniger et al., 2010). Straub et al. 
showed in vitro model of co-cultured EC and SMC that MEJ communication was enhanced by 
NO and also found that eNOS and Cx43 are present in MEJ (Straub et al., 2011). However, our 
results do not require a direct interaction of the connexin and NOS. Moreover, no acute inhibitory 
effects of NO on cells being coupled with Cx43 homotypic GJs were observed (not shown). 
 
Interestingly, NO is involved in the permeability control of another endothelial connexin, 
Cx40. Hoffmann et al. have shown that NO can enhance the de novo formation of endothelial 
GJs, thereby enhancing gap junction permeability for calcein (Hoffmann, Gloe, Pohl, & Zahler, 
2003). This effect was mediated by a PKA mediated phosphorylation of Cx40, NO increasing the 
cAMP level of endothelial cells by its inhibitory effects on cAMP degrading phosphodiesterases 
(Hoffmann et al., 2003). In contrast to the effect of NO on Cx37, this is a delayed effect which 
requires minutes to hours, whereas the effect of NO on Cx37 occurs within seconds (Hoffmann et 
al., 2003). 
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One of the aims of this study was to analyse how NO could modify the Cx37 protein so 
that a reduction of Cx37 containing gap junctions could occur. 
GJ channels can open and close in a very dynamic way. There are two models how this 
change can occur – the ball and chain model (Delmar, Coombs, Sorgen, Duffy, & Taffet, 2004), 
and a model that suggests a small rotation of each subunit which accordingly may result in 
opening or closing the channel (Alberts, 2002). Figure IV-1 depicts the latter model showing 
schematically the response of the channel conformation to changes of pH or local calcium 
concentration (Alberts, 2002). 
 
Figure IV-1 Proposed model for changes of GJ channel permeability in response to changes in Ca2+ or pH in the cytosol. 
Picture modified after (Alberts, 2002). 
Alternatively a “ball-and-chain” or “particle-receptor” model (Figure IV-2) was proposed 
e.g. as a mechanism leading to reduced permeability following intracellular acidification 
inducing GJ closing (Delmar et al., 2004; Ek-Vitorin et al., 1996; Stergiopoulos et al., 1999). 
This model suggests that the “ball” or “particle” (C-terminus domain of Cx) interacts directly 
with the “receptor” or “chain” (intercellular loop Sβ55 - A311) in order to close the GJ channels.  
 
Figure IV-2 Scheme of the “ball-and-chain” model that closes GJ channels. The ball is formed by the C-terminus domain and 
binds to the intracellular loop “receptor” domain. For clarity, only one ball and chain forming a hemichannel are indicated on the 
figure. Picture taken from (Delmar et al., 2004).  
The interaction between the C-terminus domain and the cytoplasmic loop is thought to be 
regulated by modifications of the cytoplasmatic C-terminus loop of the connexins (A. L. Harris, 
2001). The best known modifications are phosphorylations. In Cx 43, about 14 potential 
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phosphorylation sites are considered to exist (Lampe & Lau, 2004; Marquez-Rosado, Solan, 
Dunn, Norris, & Lampe, 2012; Solan & Lampe, 2009), similar numbers are reported for Cx37 
(Burt et al., 2008; Traub et al., 1998). The sequence homology of the Cx37 C-terminus and the 
Cx43 C-terminus could suggest the following similar binding sites: for MAPK Cx43-Ser282 and 
Cx37-Ser275 and for PKC Cx43-Ser368 and Cx37-Ser282 (Burt et al., 2008). It is known that 
Cx43 has in the C-terminus 2-6 tyrosine phosphorylation sites and that tyrosine phosphorylation 
of Cx43 decreases the GJ permeability (Goodenough, Goliger, & Paul, 1996)  
Several groups have shown that mouse Cx37 can be phosphorylated at serine and – to a 
smaller extent - at tyrosine and threonine residues (Traub et al., 1998); the kinases implicated in 
this process were not identified (Larson et al., 2000). Moreover, Morel et al. showed that the 
region around the polymorphic position 319 of Cx37 C-terminus could be a site for 
phosphorylation for glycogen synthase kinase-3 (GSK-3) (Morel et al., 2010). Another group 
showed that there are two polymorphic mutants of Cx37 existing in the human population one 
expressing a serine (Cx37-S319 which can be phosphorylated) and the other a proline (P/Pro) 
(Cx37-P319 which cannot be phosphorylated) at position 319 (C-terminus) and it could be shown 
that a correlation of Cx37-P319 with an increased incidence of atherosclerosis exists (Boerma et 
al., 1999; Pfenniger et al., 2010).  
We therefore tried to identify which region of the C-terminus might be involved in the 
NO dependent regulation of the permeability of Cx37 containing gap junction channels. The C-
terminus of Cx37 has serine, cysteine and tyrosine residues which are potentially subject to a 
posttranslational modification. To determine the specific site of the Cx37GFP modifications 
induced by NO, we created mutant cells in which Cx37 consisting of 333 aa (without GFP) was 
shortened at the C-terminus by 14 aa (del319), or 37 aa (del296). As pointed out already, these 
mutants showed normal incorporation into the cell membrane and no quantifiable alteration of 
their GJ calcium permeability. However, the inhibitory effect of NO on GJ calcium permeability 
was lost in these cells. This was not an unspecific effect of the mutation, since the inhibition by 
H2O2 or low pH was still present and unaltered. Moreover, the use of two different mutants 
showing the same result minimize further the risk that the lack of NO dependent inhibition was 
due to unspecific conformational changes which is always inherent in such deletion experiments. 
A sequence analysis of the C-terminus yielded only one tyrosine residue in the deleted terminal 
region which could be subject to NO induced phosphorylation or nitrosylation. Figure IV-3 
shows the polypeptide sequence of Cx37GFP schematically, black color representing the N-
terminus, yellow the 4 transmembrane domains, blue the two extracellular loops, purple the 
cytoplasmic loop cytosolic located, red the C-terminus, gray the spacer and green GFP. Several 
tyrosine residues are present in Cx37 sequence (pink Y in Figure IV-3), the C-terminus (red 
sequence) has 4 tyrosine (black arrows) and for the final 14 aa one tyrosine can be identified. 
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Figure IV-3 Polypeptide sequence of Cx37GFP were tyrosine residues are present. C-terminus with 4 tyrosine indicated by the 
black arrows and only one tyrosine observed in the last 14 aa.  
Therefore, in a further step, this tyrosine at position 332 was exchanged by alanine 
(Y332A). The experiments with the point mutation Y332A showed, that the NO effect was lost 
though the C-terminus length was not altered in this case. These results indicate that the presence 
of Y332 is an essential prerequisite for NO induced control of Cx37 dependent gap junctional 
permeability. To our knowledge, this is the first study which indicates a specific C-terminus site 
for NO effect in Cx37.  
NO could modify the tyrosine target directly or indirectly by several independent 
mechanisms: Firstly, it could exert its effect by an activation of guanylyl cyclase and the 
downstream cGMP pathway. NO is well known binding to the heme group of soluble guanylyl 
cyclase which is present in many cells thereby eliciting the enhanced formation of the second 
messenger 3`-5`cyclic guanosine monophosphate (cGMP) (Francis et al., 2010; Munzel et al., 
2003). An important downstream kinase is the protein kinase G (PKG) (Johnstone et al., 2009), 
which can phosphorylate target proteins. However, the PKG is a Ser / Thr kinase which could not 
directly phosphorylate the tyrosine residue identified here as a potential target. Moreover, we 
have shown before that the effect of NO on Cx37 is cGMP independent, since treatment with the 
sCG inhibitor ODQ (Kameritsch et al., 2005) did not prevent the effect of NO. However, there 
are a plethora of other enzymes, including tyrosine kinases or phosphatases, which could be 
activated by NO e.g. through S-nitrosylation and secondarily control the phosphorylation of 
Y332.  
Reactive cysteine thiols and NO form covalently S-nitrosothiol groups (Lima, Forrester, 
Hess, & Stamler, 2010). Most cGMP independent effects of NO are thought to be mediated via 
S-nitrosylation (Lima et al., 2010), which can induce protein modifications. Our S-nitrosylation 
assay experiments showed differences between control and SNAP treatment. The difference 
suggests that Cx37GFP could be S-nitrosylated in the presence of NO but the specific location of 
these modifications could not be localized further. Figure IV-4 depicts the localization of Cys 
residues (represented in dark blue) within the peptide sequence of Cx37GFP with following: 
black color representing the N-terminus, yellow the 4 transmembrane domains with one Cys, 
purple the cytoplasmic loop, blue the two extracellular loops with 5 Cys, grey the spacer without 
Cys, red the C-terminus with 3 Cys and green the GFP (green) with 3 Cys.  
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Figure IV-4 Cysteine residues observed in the Cx37GFP polypeptide sequence. 13 cysteine residues are present in 
Cx37GFP sequence. Cx37 has 10 Cys with 3 Cys located in the C-terminus and 3 Cys in GFP.  
 
However, del319 and del296 mutants which show a loss of NO effect have no Cys in this 
part of the C-terminus which makes a role for S-nitrosylation in our context unlikely. 
Finally, NO can react with superoxide to form peroxynitrite (Pacher, Beckman, & 
Liaudet, 2007). Peroxynitrite (ONOO-) is known e.g. to activate Mitogen activated protein kinase 
(MAPKs) and other enzymes (Liaudet, Vassalli, & Pacher, 2009). MAPK are, however, again 
Ser /Thr Kinases (Cargnello & Roux, 2011) which may, however, not directly affect Y332. 
 
Within the time constraints of this thesis it was not possible to analyse the modification of 
Y332 by mass spectrometry. While the results revealed the presence of Cx37 posttranslational 
modifications the final region of the C-terminus could not be analysed as the respective protein 
fragments could not be sufficiently recovered after treatment with several standard enzyme 
mixtures. The most common modification of tyrosine is phosphorylation. Moreover, we did also 
not find in western blot experiments distinct differences in the overall phosphorylation of 
Cx37GFP. However, the complete C-terminus of Cx37 contains four different tyrosine residues 
the variable phosphorylation of which could have masked changes in Y332.  
However, pretreatment with an inhibitor of tyrosine phosphatases, orthovanadate also 
abolished the NO effect. This suggests that NO may affect the activity of a tyrosine phosphatase 
and thereby indirectly control the phosphorylation at Y332. However, orthovanadate is not fully 
specific and can also affect the effect of ATPases (Pezza, Villarreal, Montich, & Argaraña, 2002) 
which limits the interpretability of our results. At first glance, the inhibitory effects of genistein, a 
tyrosine kinase inhibitor, on the NO effect would support the idea that NO interfered with the 
phosphorylation state of Y332. Unfortunately, genistein also reduced the calcium permeability of 
gap junctions formed by the Y332A mutant, pointing to the fact that genistein probably affects 
many phosphorylation processes in the cell.  
Our study confirmed that NO inhibits GJ communication between cells when Cx37 is 
involved. While we identify for the first time a specific amino acid residue of its C-terminus, 
Y332 as being essential for this effect, it was not designed to clarify the functional significance of 
the Cx37 dependent inhibitory effect of NO. This would be necessary to decide whether the 
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phosphorylation state of Y332 would be a potential therapeutic target and what the consequences 
of an impaired NO production or availability were on gap junctional communication. However, 
recent findings by our laboratory (Pogoda et al., 2014) may shed some light on the potential 
significance. Pogoda et al. showed that NO has effect on bidirectional GJ communication (GJC) 
between EC and SMC in co-culture and also that endothelial Cx37 are located within the internal 
elastic lamina very close to smooth muscle Cx43.  
For these reasons, we propose a functional consequence for the NO effect on MEGJ 
(Figure IV-5). Stimulation of EC leads to an increase of intracellular Ca2+concentration, which 
can pass to the neighbouring EC cells via EC GJ (acting as one functional unit) or can diffuse to 
the underlying VSM. At the same time, more nitric oxide (NO) is produced by EC, which 
reduces the calcium loss to VSM. As a consequence, calcium increases in EC, which is essential 
for endothelial autacoid synthesis and may be augmented and prolonged (Pogoda et al. 2014) 
thereby, augmenting the endothelial influence on vascular tone.  
 
Figure IV-5 The effect of NO on MEGJ communication depicts that NO, produced by the EC, diffuses to the SMC and 
produces SMC relaxation. Furthermore, at the same it blocks Cx37- containing MEGJ preventing a Ca2+-loss from EC to SMC 
and therefore increasing the endothelial response to stimulation. 
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ABBREVIATION  
 
A Alanine 
Å Angstrom 
aa Amino acid 
Ab / Abs Antibody / Antibodies 
ANOVA  one-way analysis of variance for repeated measures 
ATP Adenosine triphosphate 
bp Base pair 
BSA Bovine serum albumin 
C Celsius oder Culture 
Ca2+ Calcium ions 
CaMKII Ca2+/CaM-dependent kinase II  
cAMP Cyclic Adenosinmonophosphate 
cAMP-PKA cAMP-dependent protein kinase 
cDNA Complementary deoxyribonucleic acid 
cGMP 3`-5`cyclic guanosine monophosphate 
cl Cytoplasmic loop  
CO2 Carbon dioxide  
COOH, C-terminus Carboxyl terminus  
c-Src Proto-oncogene tyrosine-protein kinase Src 
Cx (Cxs) Connexin (Connexins) 
Cx37 or GJA4 Connexin 37 
Cx37GFP Connexin 37 full length protein (aa 1 – 333), GFP tagged 
Da Daltons 
DMEM Dulbecco’s Modified Eagle Medium 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
DNTP Deoxyribonucleotide triphosphates 
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DTT Dithiothreitol 
EC Endothelial cells 
EDHF Endothelium-derived hyperpolarizing factor  
EDTA Ethylenediaminetetraacetic acid 
el1, el2 Extracellular loop  
eNOS Endothelial NOS-3 synthase 
eNOS Endothelial NO synthase 
FCS Fetal calf serum 
for Forward 
For_1Cx37 Primer forward Cx37 
Fura 2AM Fura 2AM -acetoxymethyl 
g g=9.8m/s2 
GFP Green fluorescent protein 
gfp-for Primer forward GFP 
Gfp-rev Primer reverse GFP 
GJ  Gap junction 
GJC Gap junctions communication 
GJs Gap junctions 
GSK-3 Glycogen synthase kinase-3  
H2O water  
H2O2 Hydrogen peroxide 
HeLa Henrietta Lacks (Immortal cervix carcinoma cells) 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC High Performance Liquid Chromatography 
IHC Immunohistochemsitry 
IPI International Protein Index (human database ) 
kDa Kilo daltons 
KO Knockout  
l Liter 
LC-MS/MS Tandem mass spectrometry 
LNA N-nitro-L-arginine 
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m Mili 
m1,m2,m3,m4 Transmembrane domains  
MAPK Mitogen-activated protein kinase 
MEGJ Myoendothelial gap junctions 
MEGJs myoendothelial gap junctions  
min Minute 
ml Milliliter (10-3 liter) 
mRNA Messenger ribonucleic acid 
N Nucleus  
n Number of experiments 
NCBS New born calf serum 
NH2 / N-terminus Amino-terminus  
nm Nano meter 
NO Nitric oxide 
NOS NO synthase 
ODQ guanylyl cyclase inhibitor - oxadiazole-[4,3-a]-quinoxalin-1-one 
ONOO- Peroxynitrite  
P/ Pro Proline 
PBS- Mg2+-Ca2+ free phosphate buffered saline 
PBS+ Phosphate buffered saline 
pO2 Pressure of oxygen 
pCO2 pressure of carbon dioxide  
PCR Polymerase chain reaction 
PKA Protein kinase A 
PKC Protein kinase C 
PKG Protein kinase G 
PKG Protein kinase G 
PLC phospholipase C 
pmol Picomoli 
PMSF Phenylmethylsulfonyl fluoride 
pS Picosiemens (dimesion unit of the electrical conductance) 
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PTM Posttranslational modification 
rev Reverse  
Rev_1Cx37 Primer reverse Cx37 
RLT  Buffer denaturing guanidine-thiocyanate containing buffer with 10 
µl/ml ß-mercaptoethanol 
RNA Ribonucleic acid 
RNase Ribonuclease 
ROI Regions of interest  
RP Reversed phase 
rpm Rounds per minute 
RT Room temperature 
RT-PCR Reverse Transcription-Polymerase Chain Reaction  
s Second 
SDS Sodium dodecylsulfate 
SDS-PAGE SDS-Polyacrylamid gel electrophoresis 
SEM  Standard error of the mean 
Ser Serine  
SMC Smooth muscle cells 
SNAP S-nitroso-N-acetyl-D,L- penicillamine 
SNP sodium nitroprusside 
SOD Superoxide dismutase  
TBE  Tris-borate-EDTA 
TBS Tris buffered saline 
TBS-Tween / TBS-T Tris buffer saline Tween 
TFA Trifluoroacetic acid  
Thr Threonine 
TiO2 Titanium dioxide 
Tyr/ Y Tyrosine 
V Volts 
VSM Vascular smooth muscle  
VSMC Vascular smooth muscle cells  
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w Wells 
WB Western blot 
wt Wild-type 
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